{"gene":"STK39","run_date":"2026-06-10T10:51:54","timeline":{"discoveries":[{"year":2000,"finding":"SPAK is a serine/threonine kinase that autophosphorylates and phosphorylates exogenous substrates in vitro. Full-length SPAK localizes to the cytoplasm in transfected cells, while a caspase-cleaved form localizes predominantly to the nucleus. SPAK specifically activates the p38 MAPK pathway in cotransfection assays.","method":"In vitro kinase assay, immunofluorescence localization, cotransfection reporter assay","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — in vitro kinase assay and localization data from single lab, no replication","pmids":["10980603"],"is_preprint":false},{"year":2002,"finding":"SPAK physically interacts with the cation-chloride cotransporters NKCC1, NKCC2, and KCC3 (but not KCC1 or KCC4) via an (R/K)FX(V/I)-containing motif on the cotransporters and the C-terminal 100 amino acids of SPAK. In vivo co-immunoprecipitation of SPAK from mouse brain with anti-NKCC1 antibody was confirmed. SPAK co-localizes with NKCC1 on the apical membrane of choroid plexus epithelium; in NKCC1-null mice, SPAK redistributes to the cytoplasm.","method":"Yeast two-hybrid, GST pulldown, co-immunoprecipitation, immunohistochemistry","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (Y2H, pulldown, co-IP, IHC), replicated binding motif finding","pmids":["12386165"],"is_preprint":false},{"year":2003,"finding":"SPAK binding to NKCC1 is not required for basal cotransporter activity (NKCC1 mutant lacking SPAK binding showed identical K+ transport to wild-type). However, SPAK co-immunoprecipitates with p38 MAPK and NKCC1 in an activity-dependent manner; cellular stress reduces the amount of p38 co-immunoprecipitated with SPAK/NKCC1, while the SPAK-NKCC1 interaction remains unchanged, suggesting a scaffolding role for SPAK.","method":"86Rb+ uptake functional assay in Xenopus oocytes, co-immunoprecipitation, Western blot","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional assay plus reciprocal co-IP, single lab with two orthogonal methods","pmids":["14563843"],"is_preprint":false},{"year":2004,"finding":"SPAK is a substrate and binding partner of PKCθ. PKCθ phosphorylates SPAK at Ser311 in the kinase domain. TCR/CD28 costimulation enhances SPAK-PKCθ association and SPAK kinase activity. SPAK synergizes with constitutively active PKCθ to activate AP-1 (but not NF-κB); dominant-negative SPAK or SPAK RNAi inhibits PKCθ- and TCR/CD28-induced AP-1 activation.","method":"Co-immunoprecipitation, in vitro kinase assay, site-directed mutagenesis (S311 mutation), RNAi knockdown, reporter assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — direct phosphorylation demonstrated in vitro with mutagenesis validation plus functional epistasis in cells, single lab with multiple orthogonal methods","pmids":["14988727"],"is_preprint":false},{"year":2005,"finding":"WNK1 co-immunoprecipitates with SPAK from rat testis. WNK1 and WNK4 both phosphorylate SPAK at Thr233 (T-loop) and Ser373 (C-terminal non-catalytic region). Phosphorylation of Thr233 (equivalent to Thr185 in OSR1) by WNK1 is required for SPAK activation; T-loop mutation to Ala abolishes activation, while Glu mutation (phosphomimetic) constitutively activates the kinase.","method":"Co-immunoprecipitation, in vitro kinase assay, phosphopeptide mapping, site-directed mutagenesis","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro phosphorylation with mutagenesis and phosphopeptide mapping; independently replicated in multiple labs","pmids":["16083423"],"is_preprint":false},{"year":2005,"finding":"WNK1 phosphorylates SPAK and OSR1, activating them. SPAK and OSR1 directly phosphorylate the N-terminal regulatory regions of cation-chloride cotransporters NKCC1, NKCC2, and NCC. Hypotonic stress activates SPAK/OSR1 and induces NCC phosphorylation in cells.","method":"In vitro kinase assay, cell-based phosphorylation assay, Xenopus oocyte expression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with direct phosphorylation, independently replicated","pmids":["16263722"],"is_preprint":false},{"year":2006,"finding":"SPAK phosphorylates NKCC1 at Thr203/Thr207/Thr212 (human). The conserved C-terminal CCT domain of SPAK interacts with an RFXV motif present in both its substrate NKCC1 and its activators WNK1/WNK4; this docking interaction is required for efficient phosphorylation of NKCC1 but not of a peptide substrate lacking the RFXV motif. Mutation of specific CCT domain residues abolishes RFXV binding and prevents NKCC1 phosphorylation.","method":"In vitro kinase assay, peptide affinity purification, site-directed mutagenesis, osmotic stress cell assay","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution, mutagenesis of both kinase and substrate, multiple orthogonal approaches, single rigorous study","pmids":["16669787"],"is_preprint":false},{"year":2006,"finding":"Mutation of SPAK activation loop residues Thr243 or Thr247 to Ala prevents WNK4-mediated activation and robustly inhibits NKCC1 cotransporter activity in Xenopus oocytes. SPAK activity is inhibited by staurosporine and K252a. OSR1 exhibits similar kinase properties and functional activation of NKCC1 when coexpressed with WNK4.","method":"Site-directed mutagenesis, 86Rb+ uptake functional assay in Xenopus oocytes, in vitro kinase assay with Mn2+/Mg2+","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis of activation loop combined with functional cotransporter assay, single lab with multiple orthogonal methods","pmids":["16382158"],"is_preprint":false},{"year":2007,"finding":"Physical docking of SPAK to NKCC1 via a single RFXV-containing binding motif (mutation of the Phe residue abrogates both binding and function) is necessary for NKCC1 activation under basal and hyperosmotic conditions. SPAK docking to NKCC1 is required for efficient phosphorylation of NKCC1 at Thr206 and Thr211.","method":"Yeast two-hybrid, in vitro 32P-phosphorylation, 86Rb+ uptake assay in Xenopus oocytes, site-directed mutagenesis","journal":"Cellular physiology and biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution with mutagenesis and functional readout, multiple orthogonal methods in single lab","pmids":["17595523"],"is_preprint":false},{"year":2007,"finding":"SPAK interacts with apoptosis-associated tyrosine kinase (AATYK1) via RFXV-like binding motifs on AATYK1; disruption of these motifs abrogates AATYK1-mediated inhibition of NKCC1. AATYK1 also scaffolds protein phosphatase 1 (PP1) via a PP1-docking motif; this interaction is required for NKCC1 inhibition, suggesting AATYK1 indirectly inhibits SPAK/WNK4 activation of NKCC1 by bringing PP1 into proximity.","method":"Xenopus oocyte functional assay, yeast two-hybrid, site-directed mutagenesis","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional assay and Y2H with mutagenesis, single lab","pmids":["17267545"],"is_preprint":false},{"year":2008,"finding":"SPAK and OSR1 kinases activated by WNK1 phosphorylate human NCC at Thr46, Thr55, and Thr60. Efficient NCC phosphorylation requires docking via an RFXI motif on NCC. Mutation of Thr60 to Ala markedly inhibits phosphorylation of Thr46 and Thr55 and NCC activation. Hypotonic low-chloride conditions in HEK293 or mpkDCT cells induce SPAK/OSR1-dependent phosphorylation of NCC.","method":"In vitro kinase assay, site-directed mutagenesis, cell-based phosphorylation assay (HEK293 and mpkDCT cells)","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro phosphorylation with mutagenesis, confirmed in cell-based system, independently replicated","pmids":["18270262"],"is_preprint":false},{"year":2008,"finding":"STK39/SPAK is expressed in the distal nephron in vivo and interacts with WNK kinases and cation-chloride cotransporters in cell-based functional studies. An intronic element with allele-specific transcription activity was identified as a functional candidate for BP association, suggesting variants increase STK39 expression to alter renal Na+ excretion.","method":"In vivo expression analysis (immunohistochemistry), cell-based functional assay (co-interaction studies), reporter assay for allele-specific transcription","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — functional reporter assay and localization data, interaction confirmed in cell-based system","pmids":["19114657"],"is_preprint":false},{"year":2008,"finding":"PKCδ directly binds SPAK, phosphorylates and activates it upstream of NKCC1 in human airway epithelial cells during hyperosmotic stress. SPAK siRNA knockdown prevents NKCC1 phosphorylation and functional activation. GST pulldown confirms direct SPAK-NKCC1 interaction; a NKCC1 N-terminal peptide competitively inhibits SPAK-NKCC1 binding.","method":"RNAi knockdown, 86Rb+ flux assay, GST pulldown, recombinant protein kinase assay, competitive peptide inhibition","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — direct binding and kinase assays with functional validation by siRNA knockdown, single lab with multiple orthogonal methods","pmids":["18550547"],"is_preprint":false},{"year":2008,"finding":"WNK3 activates NKCC2 through SPAK in a chloride-sensing mechanism; intracellular Cl- depletion activates NKCC2 by promoting phosphorylation at Thr96, Thr101, and Thr111. WNK3 is positioned upstream of SPAK; elimination of WNK3's SPAK-binding motif prevents NKCC2 activation. SPAK is required for chloride-sensitive NKCC2 activation.","method":"Xenopus oocyte expression, site-directed mutagenesis, epistasis analysis with dominant-negative constructs","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with mutagenesis in functional oocyte system, single lab with multiple constructs","pmids":["18550832"],"is_preprint":false},{"year":2009,"finding":"AngII signaling increases NCC activity through a WNK4-SPAK-dependent pathway; dominant-negative SPAK or elimination of the SPAK binding motif on NCC prevents AngII-mediated NCC activation. AngII increases phosphorylation of SPAK and NCC at residues required for their activation in mpkDCT cells.","method":"Xenopus oocyte functional assay, dominant-negative SPAK constructs, mpkDCT cell phosphorylation assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — epistasis with dominant-negative and motif-mutant constructs in two independent systems, single lab","pmids":["19240212"],"is_preprint":false},{"year":2009,"finding":"SPAK silencing by shRNA in B cells protects against caspase-dependent apoptosis induced by DNA double-strand breaks but not from osmotic/oxidative stress-induced apoptosis. Caspase 3 cleavage is impaired upon SPAK repression in DNA-damaged B cells, implicating SPAK in a JNK-dependent apoptosis pathway.","method":"shRNA knockdown, caspase 3 cleavage assay, apoptosis assays, pharmacological JNK inhibition","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — functional knockdown with specific apoptosis readout, single lab","pmids":["19717643"],"is_preprint":false},{"year":2009,"finding":"SPAK knockout mice exhibit higher nociceptive thresholds, locomotor deficits (rotarod and open-field), and increased anxiety-like behavior, indicating SPAK plays an important role in CNS function consistent with regulating ion transport mechanisms involved in inhibitory neurotransmission.","method":"SPAK knockout mouse behavioral analysis (hot plate, tail flick, rotarod, open-field, light/dark box)","journal":"Behavioural brain research","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — clean knockout with defined behavioral phenotype, single lab","pmids":["20006650"],"is_preprint":false},{"year":2010,"finding":"SPAK-null mice display Gitelman syndrome phenotype (hypotension, hypokalemia, hypomagnesemia, hypocalciuria) with markedly decreased total and phosphorylated NCC in kidney, but increased p-OSR1 and p-NKCC2. In aortic tissue, NKCC1 expression increased but p-NKCC1 decreased. SPAK-null mice had impaired contractile responses to phenylephrine and bumetanide, indicating SPAK regulates both renal NCC and vascular NKCC1.","method":"Targeted gene disruption (exons 9-10), blood pressure measurement, plasma electrolytes, diuretic challenges, phospho-specific Western blot, vascular contractility assay","journal":"Journal of the American Society of Nephrology : JASN","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout mouse with comprehensive phenotyping including phospho-specific readouts and functional vascular assays","pmids":["20813865"],"is_preprint":false},{"year":2010,"finding":"SPAK knock-in mice in which SPAK cannot be activated by WNKs display significantly reduced blood pressure (salt-dependent) and markedly reduced phosphorylation of NCC and NKCC2 at SPAK-targeted residues, as well as reduced NCC and NKCC2 protein expression without mRNA changes.","method":"Knock-in mouse model (WNK-resistant SPAK), blood pressure telemetry, phospho-specific Western blot, qPCR","journal":"EMBO molecular medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knock-in with mechanistic phosphorylation readout, replicated across multiple labs","pmids":["20091762"],"is_preprint":false},{"year":2010,"finding":"PP1 directly dephosphorylates both NKCC1 and SPAK in vitro. PP1 dephosphorylation of SPAK is markedly enhanced when SPAK is scaffolded to the NKCC1 N-terminal tail; mutation of the PP1 binding motif in NKCC1 reduces PP1 inhibitory effect. The N-terminal tail of NKCC1 thus serves as a regulatory scaffold for both SPAK and PP1.","method":"In vitro dephosphorylation assay, Xenopus oocyte functional assay, site-directed mutagenesis of PP1 docking motif","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with mutagenesis and functional oocyte system, single lab","pmids":["20223824"],"is_preprint":false},{"year":2010,"finding":"SPAK substrate recognition requires two threonine residues in NKCC1 separated by four amino acids; addition or removal of a single residue abrogates SPAK-mediated NKCC1 activation. Constitutively active SPAK is created by T243E/S383D double mutation or by S383A mutation alone (which removes autoinhibition). WNK4 can phosphorylate SPAK at S321 in a deletion mutant.","method":"Site-directed mutagenesis, Xenopus oocyte 86Rb+ uptake assay","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — systematic mutagenesis with functional assay, single lab","pmids":["20463172"],"is_preprint":false},{"year":2010,"finding":"SORLA (an intracellular sorting receptor) interacts with SPAK and controls its intracellular trafficking; SORLA deficiency leads to SPAK missorting, inability to phosphorylate NKCC2, and impaired renal sodium reabsorption under osmotic stress.","method":"Co-immunoprecipitation, SORLA knockout mouse model, phospho-specific Western blot, immunofluorescence","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus knockout phenotype with phosphorylation readout, single lab","pmids":["20385770"],"is_preprint":false},{"year":2011,"finding":"A kidney-specific SPAK isoform lacking the kinase domain inhibits phosphorylation of NCC and NKCC2 by full-length SPAK in vitro. Kidney-specific SPAK is highly expressed in the thick ascending limb (TAL), while full-length SPAK predominates in the distal convoluted tubule (DCT). SPAK knockout has divergent nephron-segment-specific effects: increased p-NKCC2 in TAL but decreased p-NCC in DCT.","method":"In vitro kinase assay, SPAK knockout mouse analysis, nephron segment-specific expression analysis, phospho-specific Western blot","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro inhibition assay plus knockout phenotyping with segment-specific analysis, single lab","pmids":["21907141"],"is_preprint":false},{"year":2011,"finding":"MO25α/β bind to SPAK and OSR1 and induce ~100-fold activation of their kinase activity, dramatically enhancing their ability to phosphorylate NKCC1, NKCC2, and NCC. siRNA knockdown of MO25 in mammalian cells inhibits endogenous NKCC1 phosphorylation at SPAK/OSR1-targeted residues, rescued by MO25α re-expression.","method":"Co-immunoprecipitation, in vitro kinase assay, siRNA knockdown, MS identification of new phosphorylation sites","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro activation assay with dramatic effect plus siRNA rescue experiment, single lab with multiple orthogonal methods","pmids":["21423148"],"is_preprint":false},{"year":2011,"finding":"WNK kinases act as scaffolds to recruit SPAK to the complex with CFTR and NBCe1-B in pancreatic ductal epithelia; SPAK phosphorylates CFTR and NBCe1-B, reducing their cell surface expression. IRBIT opposes WNK/SPAK by recruiting PP1 to dephosphorylate CFTR and NBCe1-B, restoring surface expression. Silencing SPAK and IRBIT together rescues ductal secretion lost from IRBIT silencing alone.","method":"siRNA knockdown (SPAK, WNK, IRBIT), epithelial secretion assay, surface expression analysis, epistasis rescue experiment","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Moderate — epistasis demonstrated by double-knockdown rescue, functional secretion readout, single lab with multiple orthogonal methods","pmids":["21317537"],"is_preprint":false},{"year":2011,"finding":"SPAK directly phosphorylates NKCC2 isoforms at Thr95, Thr100, and Thr105 (and possibly Ser91) through docking at an RFQV motif on NKCC2. Hypotonic low-chloride conditions activate WNK1-SPAK/OSR1 pathway to phosphorylate NKCC2. In contrast to NCC, NKCC2 is constitutively at the membrane and not translocated by SPAK/OSR1 phosphorylation.","method":"In vitro kinase assay, cell-based phosphorylation assay, mutagenesis of RFQV motif","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro phosphorylation with docking motif mutagenesis, confirmed in cellular system","pmids":["21321328"],"is_preprint":false},{"year":2012,"finding":"NKCC1 is not phosphorylated or activated in SPAK/OSR1 double-knockin embryonic stem cells where both kinases cannot be activated by WNK1, establishing that SPAK and OSR1 are the essential intermediaries for WNK1-dependent NKCC1 phosphorylation. These knockin cells also exhibit markedly elevated WNK1 and WNK3 activity, revealing a feedback whereby SPAK/OSR1 suppresses WNK activity.","method":"Double-knockin ES cells, NKCC1 phosphorylation assay, WNK kinase activity measurement","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis using double-knockin cells, independently replicated finding","pmids":["22032326"],"is_preprint":false},{"year":2012,"finding":"SPAK and OSR1 co-localize with MO25α at the apical membrane of TAL and DCT. In SPAK-null mice DCT (but not TAL), OSR1 becomes largely inactive, displaced from MO25α and NCC at the apical membrane, and redistributes to dense punctate cytoplasmic structures with WNK1, resulting in decreased NCC phosphorylation and reduced DCT mass.","method":"SPAK knockout mouse analysis, co-localization immunofluorescence, phospho-specific Western blot, nephron morphometry","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — knockout mouse with subcellular localization and functional phosphorylation readouts, single lab with multiple methods","pmids":["22977235"],"is_preprint":false},{"year":2012,"finding":"SPAK and OSR1 kinases phosphorylate and activate NKCC1 in the developing hypothalamus. Estradiol increases SPAK and OSR1 protein levels via transcription-dependent mechanisms. Antisense knockdown of SPAK (and to a lesser degree OSR1) precludes estradiol-mediated NKCC1 phosphorylation enhancement and diminishes GABA-induced Ca2+ influx.","method":"Antisense oligonucleotide knockdown, Western blot, Ca2+ imaging in embryonic hypothalamic cultures","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — antisense knockdown with phosphorylation and functional calcium readout, single lab","pmids":["22238094"],"is_preprint":false},{"year":2012,"finding":"SPAK phosphorylation at S383 by WNK and p-NKCC2/p-NCC show diurnal rhythms in mouse kidney dependent on aldosterone; spironolactone treatment attenuates phosphorylation and diminishes this diurnal pattern, and exogenous aldosterone restores it.","method":"Time-course Western blot with phospho-specific antibodies, mineralocorticoid receptor antagonist treatment","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — in vivo pharmacological manipulation with phospho-specific readout, single lab","pmids":["23044422"],"is_preprint":false},{"year":2012,"finding":"The PI3K/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC cascade in hyperinsulinemic db/db mice. In SpakT243A/+ and Osr1T185A/+ knock-in db/db mice (preventing WNK-mediated activation), increased NCC phosphorylation and elevated blood pressure are completely corrected, establishing that WNK phosphorylation of SPAK/OSR1 T-loop is required for insulin/PI3K-mediated NCC activation.","method":"Knock-in mouse epistasis (T243A/T185A preventing WNK activation), PI3K/Akt inhibitor treatment, phospho-specific Western blot","journal":"Hypertension","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis using knock-in mice combined with pharmacological inhibitors, comprehensive phenotyping","pmids":["22949526"],"is_preprint":false},{"year":2013,"finding":"SPAK interacts with and phosphorylates NBCe1-B at Ser65; phosphorylation of Thr49 is required for regulation by both IRBIT and SPAK. SPAK-dependent phosphorylation of NBCe1-B and NBCn1-A is mediated through a conserved positively-charged regulatory module within residues 37-65 of NBCe1-B.","method":"Co-immunoprecipitation, mutagenesis, functional transporter assay, phospho-site identification","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis with functional transporter assay and phospho-site mapping, single lab","pmids":["23431199"],"is_preprint":false},{"year":2013,"finding":"Aldosterone acutely stimulates SPAK phosphorylation (requiring mineralocorticoid receptor and SGK1); gene silencing of SPAK eliminates aldosterone-induced NCC activity and phosphorylation. Aldosterone effects on NCC activity are SPAK-dependent.","method":"siRNA knockdown of SPAK, NCC activity assay, phospho-specific Western blot, adrenalectomized rodent model with aldosterone infusion","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown with functional NCC activity readout and in vivo confirmation, single lab","pmids":["23739593"],"is_preprint":false},{"year":2013,"finding":"SPAK-deficient mice exhibit significantly increased intestinal transepithelial resistance, decreased paracellular permeability, and altered tight junction protein expression (decreased claudin-2; increased occludin, E-cadherin, β-catenin, claudin-5). SPAK-null mice are more tolerant to DSS- and TNBS-induced colitis with increased IL-10 and decreased proinflammatory cytokines.","method":"SPAK knockout mouse analysis, transepithelial resistance measurement, permeability assay, tight junction protein expression, colitis models","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean knockout with multiple defined readouts for epithelial barrier function, single lab","pmids":["23499375"],"is_preprint":false},{"year":2014,"finding":"SPAK and OSR1 (with MO25 regulatory subunit) directly phosphorylate all KCC isoforms at a conserved C-terminal Thr residue (Site-2, Thr1048 in KCC3A), inhibiting KCC activity. In ES cells lacking SPAK/OSR1 activity, KCC Site-2 phosphorylation is abolished and KCC3A activity is elevated. A Site-2 Ala KCC3A mutant (preventing SPAK/OSR1 phosphorylation) exhibits increased activity. Thus SPAK/OSR1 coordinate reciprocal actions: stimulating NKCCs (Cl- influx) and inhibiting KCCs (Cl- efflux).","method":"In vitro kinase assay with MO25, SPAK/OSR1 double-knockin ES cells, 86Rb+ uptake assay, site-directed mutagenesis, pathway inhibitor STOCK1S-50699","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with mutagenesis, genetic ES cell model, and functional transport assay; multiple orthogonal approaches in single comprehensive study","pmids":["24393035"],"is_preprint":false},{"year":2014,"finding":"The SPAK CCT domain Leu502 residue is critical for high-affinity recognition of RFXI/V motifs in WNK1, NCC, and NKCC2; Leu502Ala knock-in mice show abolished co-immunoprecipitation of SPAK with WNK1/NCC/NKCC2, markedly reduced SPAK activity, and reduced phosphorylation and expression of NCC and NKCC2, causing Gitelman syndrome-like phenotype.","method":"Knock-in mouse model (L502A), co-immunoprecipitation, phospho-specific Western blot, blood pressure measurement, electrolyte analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — knock-in mouse model with direct biochemical validation (co-IP abolished by mutation), replicated functional consequences","pmids":["25994507"],"is_preprint":false},{"year":2014,"finding":"SPAK is important for endothelial cell proliferation (distinct from OSR1, which is required for chemotaxis/invasion) in WNK1-dependent angiogenic signaling. In HUVECs, SPAK mediates WNK1-dependent cord formation through effects on cell proliferation.","method":"HUVEC siRNA knockdown, cord formation assay, proliferation assay, chemotaxis/invasion assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown with multiple functional readouts distinguishing SPAK from OSR1, single lab","pmids":["25362046"],"is_preprint":false},{"year":2015,"finding":"Crystal structures of SPAK kinase domain (residues 63-403, at 3.1 Å) and SPAK 63-390 T243D (at 2.5 Å) reveal domain-swapped dimer architecture. The T243D activating mutation induces significant conformational changes but retains some inactive features. A monomeric SPAK mutant retains kinase activity and can be activated by WNK1 but has reduced phosphorylation of NKCC2, indicating domain swapping has regulatory roles.","method":"X-ray crystallography, site-directed mutagenesis to create monomeric mutant, in vitro kinase assay","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structures at defined resolution combined with mutagenesis and functional validation, single rigorous study","pmids":["26208601"],"is_preprint":false},{"year":2016,"finding":"ASK3 (apoptosis signal-regulating kinase 3) interacts with WNK1 and suppresses the WNK1-SPAK/OSR1 signaling pathway. ASK3 knockdown by siRNA enhances WNK1-SPAK/OSR1 activation; ASK3 knockout mice exhibit hypertensive phenotype with hyperactivation of SPAK/OSR1 in renal tubules.","method":"Co-immunoprecipitation, siRNA knockdown, ASK3 knockout mouse model, phospho-specific Western blot, blood pressure measurement","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — co-IP plus knockout mouse epistasis with phosphorylation readout, single lab with multiple orthogonal methods","pmids":["23250415"],"is_preprint":false},{"year":2017,"finding":"Constitutively active SPAK (kinase-activating mutation in Stk39 expressed DCT-specifically via Cre) causes NCC hyperphosphorylation, thiazide-treatable hypertension, and hyperkalemia. Additionally, CA-SPAK mice exhibit ASDN remodeling: reduced connecting tubule mass, attenuation of ENaC and ROMK expression and apical localization. Blocking NCC with thiazide gradually restores ASDN structure and K+ excretion.","method":"Conditional knock-in mouse (lox-P flanked CA-SPAK, DCT Cre), blood pressure telemetry, thiazide challenge, phospho-specific IHC and Western blot, urinary electrolytes","journal":"Journal of the American Society of Nephrology : JASN","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional constitutively active knock-in model with comprehensive phenotyping and pharmacological rescue","pmids":["28442491"],"is_preprint":false},{"year":2017,"finding":"Rafoxanide binds an allosteric pocket on the SPAK C-terminal (CCT) domain and inhibits SPAK and OSR1 activity in an ATP-independent manner.","method":"In silico screening, biochemical binding assay, in vitro kinase inhibition assay","journal":"ChemMedChem","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — binding and inhibition demonstrated biochemically; allosteric site identification, single lab","pmids":["28371477"],"is_preprint":false},{"year":2018,"finding":"Verteporfin binds the kinase domain of SPAK and OSR1 and inhibits their catalytic activity in an ATP-independent manner. In cells, verteporfin suppresses SPAK/OSR1-dependent phosphorylation of NKCC1.","method":"Binding assay, in vitro kinase assay, cell-based NKCC1 phosphorylation assay","journal":"Chembiochem","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — biochemical binding and in vitro inhibition confirmed in cellular system, single lab","pmids":["29999233"],"is_preprint":false},{"year":2019,"finding":"WNK bodies in the distal convoluted tubule contain phosphorylated SPAK/OSR1 under K+-deprived conditions. In WNK4-deficient mice, WNK bodies still form but contain unphosphorylated SPAK/OSR1, indicating WNK4 is the primary active kinase catalyzing SPAK/OSR1 phosphorylation within WNK bodies.","method":"Immunofluorescence microscopy in dietary K+ manipulation mouse models, WNK4-deficient and Kir4.1-deficient mice","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo localization with genetic epistasis using multiple knockout/deficient lines, single lab","pmids":["31736353"],"is_preprint":false},{"year":2020,"finding":"ZT-1a, a selective SPAK inhibitor, decreases SPAK-dependent phosphorylation of NKCC1 and increases KCC-mediated Cl- efflux in brain. Intracerebroventricular ZT-1a reduces CSF hypersecretion in post-hemorrhagic hydrocephalus model; systemic ZT-1a reduces ischemia-induced CCC phosphorylation, attenuates cerebral edema, and improves stroke outcomes.","method":"Selective SPAK inhibitor (ZT-1a) treatment in rodent models of hydrocephalus and stroke, CCC phosphorylation assay, brain water content, neurological scoring","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — pharmacological inhibition with mechanistic phosphorylation readout in two disease models, single lab with multiple orthogonal readouts","pmids":["31911626"],"is_preprint":false},{"year":2021,"finding":"STK39/SPAK interacts with PLK1 by mass spectrometry; STK39 promotes HCC progression and activates ERK signaling in a PLK1-dependent manner. STK39 knockdown causes G2/M cell cycle arrest and apoptosis in HCC cells; overexpression promotes proliferation, migration, and invasion.","method":"Mass spectrometry, co-immunoprecipitation, RNA-seq pathway analysis, gain/loss-of-function assays in HCC cells","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — MS-identified interaction and epistasis (PLK1-dependent ERK activation) with functional knockdown/OE, single lab","pmids":["33500714"],"is_preprint":false},{"year":2021,"finding":"STK39 directly phosphorylates SNAI1 at Thr203, which is critical for SNAI1 nuclear retention and stability. STK39 inhibition or knockdown destabilizes SNAI1, impairs EMT, and decreases tumor cell migration, invasion, and metastasis in vitro and in vivo; effects are rescued by ectopic SNAI1 expression.","method":"Co-immunoprecipitation, in vitro kinase assay with phospho-site mutagenesis (T203), subcellular fractionation, loss-of-function assays, xenograft rescue experiment","journal":"Theranostics","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct phosphorylation of SNAI1 at defined site with mutagenesis validation and functional rescue in vivo, single lab with multiple orthogonal methods","pmids":["34335956"],"is_preprint":false},{"year":2021,"finding":"High extracellular K+ rapidly dephosphorylates SPAK in vitro (HEK293 cells) and ex vivo (kidney slices), causing dissolution of SPAK puncta in DCT1 in vivo. The WNK4-SPAK 'on' switch must be turned off for rapid NCC dephosphorylation by high K+; longer-term WNK-SPAK stimulation attenuates sensitivity to rapid K+-induced NCC dephosphorylation. Neither PP1 nor PP3 alone or together is essential for rapid NCC dephosphorylation.","method":"In vitro kinase/phosphatase assay in HEK293 cells, ex vivo kidney slice, in vivo dietary K+ challenge with immunofluorescence and Western blot, phosphatase inhibitor experiments","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple experimental systems (in vitro, ex vivo, in vivo) with pharmacological dissection, single lab","pmids":["33719576"],"is_preprint":false}],"current_model":"STK39/SPAK is a STE20-family serine/threonine kinase that is activated by WNK kinases (primarily WNK1, WNK3, and WNK4) through phosphorylation of its T-loop Thr243 by WNKs; once activated (further stimulated ~100-fold by the co-activator MO25), SPAK directly phosphorylates and stimulates Na+-driven cation-chloride cotransporters (NKCC1, NKCC2, NCC) while also directly phosphorylating and inhibiting K+-driven KCCs—coordinated reciprocal actions that increase net intracellular Cl- and maintain ionic homeostasis; this docking-dependent mechanism requires the conserved CCT domain of SPAK to recognize RFXV/I motifs on both upstream WNK activators and downstream cotransporter substrates; SPAK also participates in stress signaling (activating p38 and JNK via RELT and PKCθ-AP-1 pathways), regulates epithelial secretion by phosphorylating CFTR and NBCe1-B, phosphorylates SNAI1 at Thr203 to promote nuclear retention and EMT, and in vivo is essential for renal salt reabsorption, blood pressure regulation, and normal CNS function."},"narrative":{"mechanistic_narrative":"STK39/SPAK is a STE20-family serine/threonine kinase that functions as the central effector linking WNK kinase signaling to ion cotransporter regulation, thereby controlling intracellular chloride homeostasis, renal salt reabsorption, and blood pressure [PMID:16263722, PMID:20091762]. SPAK is activated when WNK kinases (WNK1, WNK3, WNK4) phosphorylate its T-loop threonine (Thr233/Thr243), a modification required for catalytic activation and further amplified ~100-fold by the co-activator MO25 [PMID:16083423, PMID:21423148]. SPAK recognizes both its upstream activators and downstream substrates through its conserved C-terminal CCT domain, which docks onto RFX(V/I) motifs; the Leu502 residue of this domain is critical for high-affinity binding, and disrupting docking abolishes substrate phosphorylation in vitro and in vivo [PMID:16669787, PMID:25994507]. Through this docking-dependent mechanism SPAK directly phosphorylates the N-terminal regulatory regions of the Na+-driven cotransporters NKCC1, NKCC2, and NCC to stimulate Cl- influx, while phosphorylating a conserved C-terminal site on the K+-driven KCCs to inhibit them, executing coordinated reciprocal control of net intracellular chloride [PMID:16263722, PMID:21321328, PMID:24393035]. In vivo this axis is essential for distal nephron NCC/NKCC2 function: loss of SPAK or its WNK-mediated activation produces Gitelman-syndrome-like salt wasting and hypotension, whereas constitutive SPAK activation drives thiazide-treatable hypertension and hyperkalemia [PMID:20813865, PMID:20091762, PMID:28442491]. The pathway integrates hormonal and physiological inputs including angiotensin II, aldosterone, and insulin/PI3K signaling, and SPAK activity is opposed by phosphatase recruitment (PP1 scaffolded via cotransporter tails) and by upstream regulators such as ASK3 [PMID:19240212, PMID:22949526, PMID:20223824, PMID:23250415]. Beyond ion transport, SPAK contributes to stress and immune signaling—activating p38 and synergizing with PKCθ to drive AP-1 [PMID:10980603, PMID:14988727]—regulates epithelial secretion by phosphorylating CFTR and NBCe1-B [PMID:21317537, PMID:23431199], and in cancer promotes EMT and metastasis by directly phosphorylating SNAI1 at Thr203 to stabilize it [PMID:34335956].","teleology":[{"year":2000,"claim":"Established SPAK as a catalytically active serine/threonine kinase and first linked it to stress MAPK signaling, defining its enzymatic identity before any transport role was known.","evidence":"In vitro kinase assay, immunofluorescence, and cotransfection reporter assay","pmids":["10980603"],"confidence":"Medium","gaps":["No physiological substrate identified","Caspase-cleaved nuclear form's function unresolved"]},{"year":2002,"claim":"Identified the cation-chloride cotransporters as physical SPAK partners and defined the (R/K)FX(V/I)-docking motif, establishing the molecular basis for substrate recognition.","evidence":"Yeast two-hybrid, GST pulldown, co-IP from brain, and choroid plexus immunohistochemistry","pmids":["12386165"],"confidence":"High","gaps":["Binding alone did not establish a catalytic/regulatory consequence","Upstream activator of SPAK still unknown"]},{"year":2003,"claim":"Showed SPAK can act as an activity-dependent scaffold linking p38 to NKCC1 rather than a direct transport regulator, raising the question of how SPAK actually controls cotransporter function.","evidence":"86Rb+ uptake in Xenopus oocytes and reciprocal co-IP","pmids":["14563843"],"confidence":"Medium","gaps":["Did not resolve whether SPAK phosphorylates the cotransporter","Scaffolding vs catalytic roles not separated"]},{"year":2004,"claim":"Placed SPAK in T-cell receptor signaling as a PKCθ substrate driving AP-1, expanding its role beyond transport into immune stress signaling.","evidence":"Co-IP, in vitro kinase assay, S311 mutagenesis, RNAi, and reporter assays","pmids":["14988727"],"confidence":"High","gaps":["Direct AP-1-relevant substrate of SPAK not identified","Relationship to transport functions unclear"]},{"year":2005,"claim":"Identified WNK kinases as the upstream activators that phosphorylate the SPAK T-loop, and showed SPAK directly phosphorylates NKCC1/NKCC2/NCC, defining the core WNK–SPAK–cotransporter cascade.","evidence":"Co-IP, in vitro kinase assays, phosphopeptide mapping, T-loop mutagenesis, and oocyte expression","pmids":["16083423","16263722"],"confidence":"High","gaps":["Docking requirement for efficient phosphorylation not yet mechanistically defined","Physiological stimulus integration unknown"]},{"year":2006,"claim":"Defined the CCT-domain/RFXV docking mechanism and the activation-loop threonines as jointly required for substrate phosphorylation and cotransporter activation, unifying recognition and catalysis.","evidence":"In vitro kinase assays, peptide affinity purification, and activation-loop/CCT mutagenesis with oocyte transport assays","pmids":["16669787","16382158"],"confidence":"High","gaps":["Structural basis of docking not yet visualized","Quantitative contribution of docking to in vivo regulation unaddressed"]},{"year":2008,"claim":"Extended the cascade to NCC and NKCC2 with defined phospho-sites and docking motifs, and identified additional upstream activating kinases (PKCδ) and a Cl--sensing WNK3 input, mapping how the pathway integrates osmotic/ionic stress.","evidence":"In vitro kinase assays, RNAi, GST pulldown, and oocyte functional assays with motif mutagenesis","pmids":["18270262","18550547","18550832"],"confidence":"High","gaps":["Mechanism of chloride sensing not fully resolved","Cross-talk between PKC and WNK activation inputs unclear"]},{"year":2009,"claim":"Connected SPAK genetic variation to blood pressure and demonstrated hormonal (angiotensin II) input, linking the molecular cascade to human cardiovascular physiology.","evidence":"Allele-specific reporter assay, immunohistochemistry, and AngII oocyte/mpkDCT epistasis with dominant-negative SPAK","pmids":["19114657","19240212"],"confidence":"Medium","gaps":["Causal variant mechanism on expression incompletely defined","AngII-to-SPAK signaling intermediates unmapped"]},{"year":2010,"claim":"Established SPAK as physiologically essential for renal NCC/NKCC2 regulation and blood pressure via knockout and WNK-resistant knock-in mice, and defined opposing PP1 dephosphorylation and SORLA-dependent trafficking that tune the pathway.","evidence":"Knockout and knock-in mouse phenotyping with phospho-specific Westerns, in vitro PP1 dephosphorylation, and SORLA co-IP/knockout","pmids":["20813865","20091762","20223824","20385770","20463172"],"confidence":"High","gaps":["Phosphatase identity for in vivo dephosphorylation not fully resolved","Nephron-segment-specific divergence not yet explained"]},{"year":2011,"claim":"Identified MO25 as the ~100-fold co-activator, resolved nephron-segment-specific regulation via a kinase-dead kidney SPAK isoform, and extended SPAK to epithelial secretion (CFTR/NBCe1-B) and angiogenesis.","evidence":"In vitro activation assays, siRNA rescue, segment-specific knockout analysis, secretion/epistasis assays, and HUVEC functional assays","pmids":["21423148","21907141","21317537","21321328","25362046"],"confidence":"High","gaps":["Regulation balancing full-length vs kinase-dead isoforms unclear","Mechanism of SPAK in proliferation distinct from transport undefined"]},{"year":2012,"claim":"Proved genetically (SPAK/OSR1 double-knockin ES cells) that SPAK/OSR1 are obligatory intermediaries for WNK1-dependent NKCC1 phosphorylation and revealed feedback suppression of WNK activity, plus aldosterone/insulin hormonal control of the axis.","evidence":"Double-knockin ES cells, knockout mouse localization, knock-in epistasis with PI3K inhibitors, and aldosterone time-course Westerns","pmids":["22032326","22977235","22238094","23044422","22949526"],"confidence":"High","gaps":["Molecular basis of SPAK/OSR1-to-WNK feedback unresolved","Integration of multiple hormonal inputs at the kinase level unclear"]},{"year":2013,"claim":"Defined SPAK phospho-sites and regulatory module on NBCe1-B and demonstrated SPAK's role in intestinal epithelial barrier and inflammation, broadening its functional reach beyond cation-chloride transport.","evidence":"Co-IP/mutagenesis with transporter assays, aldosterone siRNA studies, and knockout mouse barrier and colitis phenotyping","pmids":["23431199","23739593","23499375"],"confidence":"Medium","gaps":["Mechanism linking SPAK to tight junction protein expression unknown","Direct vs indirect effects on barrier function not separated"]},{"year":2014,"claim":"Demonstrated reciprocal KCC inhibition by SPAK/OSR1 (completing the coordinated Cl- influx/efflux model) and validated CCT-domain Leu502 docking as essential in vivo, while identifying ASK3 as a negative regulator.","evidence":"In vitro kinase assays with MO25, double-knockin ES cells, KCC3A Site-2 mutagenesis, L502A knock-in mice, and ASK3 knockout phenotyping","pmids":["24393035","25994507","23250415"],"confidence":"High","gaps":["Determinants of NKCC-activating vs KCC-inhibiting substrate selection unclear","ASK3-WNK regulatory mechanism not fully defined"]},{"year":2015,"claim":"Provided crystal structures of the SPAK kinase domain revealing a regulatory domain-swapped dimer architecture, giving a structural basis for activation and substrate phosphorylation.","evidence":"X-ray crystallography of wild-type and T243D SPAK with monomeric-mutant functional assays","pmids":["26208601"],"confidence":"High","gaps":["Full activated state with substrate not captured","Functional role of dimerization in vivo not established"]},{"year":2017,"claim":"Showed via DCT-specific constitutively active SPAK mice that hyperactive SPAK alone causes thiazide-treatable hypertension with downstream ASDN remodeling, directly proving SPAK as a driver of salt-sensitive hypertension.","evidence":"Conditional CA-SPAK knock-in mice, blood pressure telemetry, thiazide rescue, and phospho-specific IHC/Western","pmids":["28442491"],"confidence":"High","gaps":["Mechanism of ENaC/ROMK downregulation downstream of NCC hyperactivity not fully defined"]},{"year":2018,"claim":"Advanced SPAK as a druggable target by identifying ATP-independent inhibitors binding the CCT or kinase domain, establishing distinct allosteric inhibition strategies.","evidence":"In silico screening, biochemical binding, and in vitro/cell-based kinase inhibition assays (rafoxanide, verteporfin)","pmids":["28371477","29999233"],"confidence":"Medium","gaps":["In vivo selectivity and efficacy not established in these reports","Binding-site structural detail limited"]},{"year":2020,"claim":"Demonstrated therapeutic potential of selective SPAK inhibition in CNS disease by reducing NKCC1 phosphorylation and CSF hypersecretion and improving stroke/edema outcomes, linking SPAK control of brain ion transport to neurological pathology.","evidence":"ZT-1a treatment in rodent hydrocephalus and stroke models with CCC phosphorylation and brain water readouts","pmids":["31911626"],"confidence":"High","gaps":["Cell-type-specific contributions in brain not dissected","Long-term consequences of SPAK inhibition undefined"]},{"year":2021,"claim":"Revealed novel SPAK functions in cancer—a PLK1-dependent pro-tumor role and direct SNAI1 Thr203 phosphorylation stabilizing SNAI1 to drive EMT/metastasis—and refined the rapid K+-triggered 'off-switch' regulation of NCC phosphorylation.","evidence":"Mass spec, co-IP, in vitro kinase/SNAI1 mutagenesis with xenograft rescue, and in vitro/ex vivo/in vivo K+ phosphatase studies","pmids":["33500714","34335956","33719576"],"confidence":"High","gaps":["Phosphatase mediating rapid K+-induced dephosphorylation unidentified","Mechanistic basis of SPAK-PLK1 cooperation in ERK activation unclear"]},{"year":null,"claim":"How SPAK selects between activating NKCCs and inhibiting KCCs at the catalytic level, the identity of the phosphatase(s) executing rapid in vivo dephosphorylation, and the reconciliation of its transport-kinase role with its emerging oncogenic SNAI1/PLK1 functions remain open.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model of substrate-specific opposing outputs","In vivo dephosphorylating phosphatase undefined","Transport vs cancer functions not mechanistically connected"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[5,6,10,25,34,45]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[4,5,31,45]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[3]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,1]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,27]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[5,25,34]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,14,30]}],"complexes":[],"partners":["WNK1","WNK4","WNK3","NKCC1","NCC","NKCC2","MO25","OSR1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9UEW8","full_name":"STE20/SPS1-related proline-alanine-rich protein kinase","aliases":["DCHT","Serine/threonine-protein kinase 39"],"length_aa":545,"mass_kda":59.5,"function":"Effector serine/threonine-protein kinase component of the WNK-SPAK/OSR1 kinase cascade, which is involved in various processes, such as ion transport, response to hypertonic stress and blood pressure (PubMed:16669787, PubMed:18270262, PubMed:21321328, PubMed:34289367). Specifically recognizes and binds proteins with a RFXV motif (PubMed:16669787, PubMed:21321328). Acts downstream of WNK kinases (WNK1, WNK2, WNK3 or WNK4): following activation by WNK kinases, catalyzes phosphorylation of ion cotransporters, such as SLC12A1/NKCC2, SLC12A2/NKCC1, SLC12A3/NCC, SLC12A5/KCC2 or SLC12A6/KCC3, regulating their activity (PubMed:21321328). Mediates regulatory volume increase in response to hyperosmotic stress by catalyzing phosphorylation of ion cotransporters SLC12A1/NKCC2, SLC12A2/NKCC1 and SLC12A6/KCC3 downstream of WNK1 and WNK3 kinases (PubMed:12740379, PubMed:16669787, PubMed:21321328). Phosphorylation of Na-K-Cl cotransporters SLC12A2/NKCC1 and SLC12A2/NKCC1 promote their activation and ion influx; simultaneously, phosphorylation of K-Cl cotransporters SLC12A5/KCC2 and SLC12A6/KCC3 inhibit their activity, blocking ion efflux (PubMed:16669787, PubMed:19665974, PubMed:21321328). Acts as a regulator of NaCl reabsorption in the distal nephron by mediating phosphorylation and activation of the thiazide-sensitive Na-Cl cotransporter SLC12A3/NCC in distal convoluted tubule cells of kidney downstream of WNK4 (PubMed:18270262). Mediates the inhibition of SLC4A4, SLC26A6 as well as CFTR activities (By similarity). Phosphorylates RELT (By similarity)","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9UEW8/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/STK39","classification":"Not Classified","n_dependent_lines":8,"n_total_lines":1208,"dependency_fraction":0.006622516556291391},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/STK39","total_profiled":1310},"omim":[{"mim_id":"614495","title":"PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D","url":"https://www.omim.org/entry/614495"},{"mim_id":"607648","title":"SERINE/THREONINE PROTEIN KINASE 39; STK39","url":"https://www.omim.org/entry/607648"},{"mim_id":"606249","title":"PROTEIN KINASE, LYSINE-DEFICIENT 2; WNK2","url":"https://www.omim.org/entry/606249"},{"mim_id":"605775","title":"KELCH-LIKE 3; KLHL3","url":"https://www.omim.org/entry/605775"},{"mim_id":"604046","title":"OXIDATIVE STRESS-RESPONSIVE 1; OXSR1","url":"https://www.omim.org/entry/604046"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Vesicles","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/STK39"},"hgnc":{"alias_symbol":["DCHT","SPAK"],"prev_symbol":[]},"alphafold":{"accession":"Q9UEW8","domains":[{"cath_id":"3.30.200.20","chopping":"61-138","consensus_level":"medium","plddt":85.4486,"start":61,"end":138},{"cath_id":"1.10.510.10","chopping":"142-222_230-362","consensus_level":"high","plddt":87.1351,"start":142,"end":362},{"cath_id":"3.10.20.90","chopping":"453-545","consensus_level":"high","plddt":86.4892,"start":453,"end":545}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UEW8","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UEW8-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UEW8-F1-predicted_aligned_error_v6.png","plddt_mean":75.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=STK39","jax_strain_url":"https://www.jax.org/strain/search?query=STK39"},"sequence":{"accession":"Q9UEW8","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UEW8.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UEW8/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UEW8"}},"corpus_meta":[{"pmid":"16083423","id":"PMC_16083423","title":"The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases.","date":"2005","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16083423","citation_count":435,"is_preprint":false},{"pmid":"16263722","id":"PMC_16263722","title":"WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16263722","citation_count":392,"is_preprint":false},{"pmid":"18270262","id":"PMC_18270262","title":"Activation of the thiazide-sensitive Na+-Cl- cotransporter by the WNK-regulated kinases SPAK and OSR1.","date":"2008","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/18270262","citation_count":320,"is_preprint":false},{"pmid":"12386165","id":"PMC_12386165","title":"Cation chloride cotransporters interact with the stress-related kinases Ste20-related proline-alanine-rich kinase (SPAK) and oxidative stress response 1 (OSR1).","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12386165","citation_count":318,"is_preprint":false},{"pmid":"16669787","id":"PMC_16669787","title":"Functional interactions of the SPAK/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16669787","citation_count":262,"is_preprint":false},{"pmid":"18843116","id":"PMC_18843116","title":"The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway.","date":"2008","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/18843116","citation_count":250,"is_preprint":false},{"pmid":"20813865","id":"PMC_20813865","title":"SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction.","date":"2010","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/20813865","citation_count":239,"is_preprint":false},{"pmid":"19114657","id":"PMC_19114657","title":"From the Cover: Whole-genome association study identifies STK39 as a hypertension susceptibility gene.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19114657","citation_count":237,"is_preprint":false},{"pmid":"20091762","id":"PMC_20091762","title":"Role of the WNK-activated SPAK kinase in regulating blood pressure.","date":"2010","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20091762","citation_count":227,"is_preprint":false},{"pmid":"25028718","id":"PMC_25028718","title":"The WNK-SPAK/OSR1 pathway: master regulator of cation-chloride cotransporters.","date":"2014","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/25028718","citation_count":214,"is_preprint":false},{"pmid":"19240212","id":"PMC_19240212","title":"Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19240212","citation_count":201,"is_preprint":false},{"pmid":"18550832","id":"PMC_18550832","title":"Regulation of NKCC2 by a chloride-sensing mechanism involving the WNK3 and SPAK kinases.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18550832","citation_count":195,"is_preprint":false},{"pmid":"21907141","id":"PMC_21907141","title":"A SPAK isoform switch modulates renal salt transport and blood pressure.","date":"2011","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21907141","citation_count":182,"is_preprint":false},{"pmid":"24393035","id":"PMC_24393035","title":"The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters.","date":"2014","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/24393035","citation_count":177,"is_preprint":false},{"pmid":"14563843","id":"PMC_14563843","title":"Characterization of the interaction of the stress kinase SPAK with the Na+-K+-2Cl- cotransporter in the nervous system: evidence for a scaffolding role of the kinase.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14563843","citation_count":175,"is_preprint":false},{"pmid":"18800028","id":"PMC_18800028","title":"Dietary salt regulates the phosphorylation of OSR1/SPAK kinases and the sodium chloride cotransporter through aldosterone.","date":"2008","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/18800028","citation_count":170,"is_preprint":false},{"pmid":"18092945","id":"PMC_18092945","title":"SPAK and OSR1: STE20 kinases involved in the regulation of ion homoeostasis and volume control in mammalian cells.","date":"2008","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/18092945","citation_count":163,"is_preprint":false},{"pmid":"21321328","id":"PMC_21321328","title":"Regulation of the NKCC2 ion cotransporter by SPAK-OSR1-dependent and -independent pathways.","date":"2011","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/21321328","citation_count":162,"is_preprint":false},{"pmid":"16382158","id":"PMC_16382158","title":"Characterization of SPAK and OSR1, regulatory kinases of the Na-K-2Cl cotransporter.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16382158","citation_count":136,"is_preprint":false},{"pmid":"10980603","id":"PMC_10980603","title":"SPAK, a STE20/SPS1-related kinase that activates the p38 pathway.","date":"2000","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10980603","citation_count":122,"is_preprint":false},{"pmid":"21423148","id":"PMC_21423148","title":"MO25 is a master regulator of SPAK/OSR1 and MST3/MST4/YSK1 protein kinases.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/21423148","citation_count":122,"is_preprint":false},{"pmid":"28442491","id":"PMC_28442491","title":"Constitutively Active SPAK Causes Hyperkalemia by Activating NCC and Remodeling Distal Tubules.","date":"2017","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/28442491","citation_count":120,"is_preprint":false},{"pmid":"22977235","id":"PMC_22977235","title":"SPAK isoforms and OSR1 regulate sodium-chloride co-transporters in a nephron-specific manner.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22977235","citation_count":119,"is_preprint":false},{"pmid":"23073627","id":"PMC_23073627","title":"Molecular physiology of SPAK and OSR1: two Ste20-related protein kinases regulating ion transport.","date":"2012","source":"Physiological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/23073627","citation_count":115,"is_preprint":false},{"pmid":"22032326","id":"PMC_22032326","title":"SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform interactions and activation by T-loop trans-autophosphorylation.","date":"2012","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/22032326","citation_count":114,"is_preprint":false},{"pmid":"31911626","id":"PMC_31911626","title":"Modulation of brain cation-Cl- cotransport via the SPAK kinase inhibitor ZT-1a.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31911626","citation_count":88,"is_preprint":false},{"pmid":"23393317","id":"PMC_23393317","title":"SPAK differentially mediates vasopressin effects on sodium cotransporters.","date":"2013","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/23393317","citation_count":88,"is_preprint":false},{"pmid":"21317537","id":"PMC_21317537","title":"IRBIT governs epithelial secretion in mice by antagonizing the WNK/SPAK kinase pathway.","date":"2011","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/21317537","citation_count":87,"is_preprint":false},{"pmid":"22949526","id":"PMC_22949526","title":"Phosphatidylinositol 3-kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in hyperinsulinemic db/db mice.","date":"2012","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/22949526","citation_count":87,"is_preprint":false},{"pmid":"15767308","id":"PMC_15767308","title":"Hypotonic shock mediation by p38 MAPK, JNK, PKC, FAK, OSR1 and SPAK in osmosensing chloride secreting cells of killifish opercular epithelium.","date":"2005","source":"The Journal of experimental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15767308","citation_count":86,"is_preprint":false},{"pmid":"25113964","id":"PMC_25113964","title":"WNK-SPAK-NCC cascade revisited: WNK1 stimulates the activity of the Na-Cl cotransporter via SPAK, an effect antagonized by WNK4.","date":"2014","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/25113964","citation_count":82,"is_preprint":false},{"pmid":"22549242","id":"PMC_22549242","title":"Aldosterone does not require angiotensin II to activate NCC through a WNK4-SPAK-dependent pathway.","date":"2012","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22549242","citation_count":76,"is_preprint":false},{"pmid":"14988727","id":"PMC_14988727","title":"SPAK kinase is a substrate and target of PKCtheta in T-cell receptor-induced AP-1 activation pathway.","date":"2004","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/14988727","citation_count":75,"is_preprint":false},{"pmid":"23431199","id":"PMC_23431199","title":"Convergence of IRBIT, phosphatidylinositol (4,5) bisphosphate, and WNK/SPAK kinases in regulation of the Na+-HCO3- cotransporters family.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23431199","citation_count":68,"is_preprint":false},{"pmid":"25362046","id":"PMC_25362046","title":"Actions of the protein kinase WNK1 on endothelial cells are differentially mediated by its substrate kinases OSR1 and SPAK.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25362046","citation_count":61,"is_preprint":false},{"pmid":"23250415","id":"PMC_23250415","title":"ASK3 responds to osmotic stress and regulates blood pressure by suppressing WNK1-SPAK/OSR1 signaling in the kidney.","date":"2012","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/23250415","citation_count":61,"is_preprint":false},{"pmid":"25377078","id":"PMC_25377078","title":"Discovery of Novel SPAK Inhibitors That Block WNK Kinase Signaling to Cation Chloride Transporters.","date":"2014","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/25377078","citation_count":60,"is_preprint":false},{"pmid":"21486947","id":"PMC_21486947","title":"Phenotypes of pseudohypoaldosteronism type II caused by the WNK4 D561A missense mutation are dependent on the WNK-OSR1/SPAK kinase cascade.","date":"2011","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/21486947","citation_count":58,"is_preprint":false},{"pmid":"25651563","id":"PMC_25651563","title":"SPAK-mediated NCC regulation in response to low-K+ diet.","date":"2015","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25651563","citation_count":56,"is_preprint":false},{"pmid":"17595523","id":"PMC_17595523","title":"A single binding motif is required for SPAK activation of the Na-K-2Cl cotransporter.","date":"2007","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17595523","citation_count":56,"is_preprint":false},{"pmid":"17032814","id":"PMC_17032814","title":"Genome-wide analysis of SPAK/OSR1 binding motifs.","date":"2006","source":"Physiological genomics","url":"https://pubmed.ncbi.nlm.nih.gov/17032814","citation_count":55,"is_preprint":false},{"pmid":"31736353","id":"PMC_31736353","title":"WNK bodies cluster WNK4 and SPAK/OSR1 to promote NCC activation in hypokalemia.","date":"2019","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31736353","citation_count":54,"is_preprint":false},{"pmid":"27068441","id":"PMC_27068441","title":"SPAK and OSR1 play essential roles in potassium homeostasis through actions on the distal convoluted tubule.","date":"2016","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27068441","citation_count":53,"is_preprint":false},{"pmid":"16734747","id":"PMC_16734747","title":"SPAK and OSR1, key kinases involved in the regulation of chloride transport.","date":"2006","source":"Acta physiologica (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16734747","citation_count":51,"is_preprint":false},{"pmid":"20463172","id":"PMC_20463172","title":"On the substrate recognition and negative regulation of SPAK, a kinase modulating Na+-K+-2Cl- cotransport activity.","date":"2010","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20463172","citation_count":51,"is_preprint":false},{"pmid":"17267545","id":"PMC_17267545","title":"Apoptosis-associated tyrosine kinase scaffolding of protein phosphatase 1 and SPAK reveals a novel pathway for Na-K-2C1 cotransporter regulation.","date":"2007","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17267545","citation_count":51,"is_preprint":false},{"pmid":"24019400","id":"PMC_24019400","title":"Dietary salt intake regulates WNK3-SPAK-NKCC1 phosphorylation cascade in mouse aorta through angiotensin II.","date":"2013","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/24019400","citation_count":50,"is_preprint":false},{"pmid":"21610494","id":"PMC_21610494","title":"Role of SPAK and OSR1 signalling in the regulation of NaCl cotransporters.","date":"2011","source":"Current opinion in nephrology and hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/21610494","citation_count":49,"is_preprint":false},{"pmid":"20223824","id":"PMC_20223824","title":"Multiple pathways for protein phosphatase 1 (PP1) regulation of Na-K-2Cl cotransporter (NKCC1) function: the N-terminal tail of the Na-K-2Cl cotransporter serves as a regulatory scaffold for Ste20-related proline/alanine-rich kinase (SPAK) AND PP1.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20223824","citation_count":49,"is_preprint":false},{"pmid":"20385770","id":"PMC_20385770","title":"SORLA/SORL1 functionally interacts with SPAK to control renal activation of Na(+)-K(+)-Cl(-) cotransporter 2.","date":"2010","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20385770","citation_count":46,"is_preprint":false},{"pmid":"23739593","id":"PMC_23739593","title":"Aldosterone acutely stimulates NCC activity via a SPAK-mediated pathway.","date":"2013","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23739593","citation_count":46,"is_preprint":false},{"pmid":"18348195","id":"PMC_18348195","title":"An analysis of candidate autism loci on chromosome 2q24-q33: evidence for association to the STK39 gene.","date":"2008","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18348195","citation_count":43,"is_preprint":false},{"pmid":"31165006","id":"PMC_31165006","title":"The WNK-SPAK/OSR1 Kinases and the Cation-Chloride Cotransporters as Therapeutic Targets for Neurological Diseases.","date":"2019","source":"Aging and disease","url":"https://pubmed.ncbi.nlm.nih.gov/31165006","citation_count":43,"is_preprint":false},{"pmid":"33192599","id":"PMC_33192599","title":"Physiological Processes Modulated by the Chloride-Sensitive WNK-SPAK/OSR1 Kinase Signaling Pathway and the Cation-Coupled Chloride Cotransporters.","date":"2020","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33192599","citation_count":43,"is_preprint":false},{"pmid":"16530727","id":"PMC_16530727","title":"The TNF receptor, RELT, binds SPAK and uses it to mediate p38 and JNK activation.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16530727","citation_count":40,"is_preprint":false},{"pmid":"25086033","id":"PMC_25086033","title":"Hypotonicity stimulates potassium flux through the WNK-SPAK/OSR1 kinase cascade and the Ncc69 sodium-potassium-2-chloride cotransporter in the Drosophila renal tubule.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25086033","citation_count":40,"is_preprint":false},{"pmid":"28371477","id":"PMC_28371477","title":"Rafoxanide and Closantel Inhibit SPAK and OSR1 Kinases by Binding to a Highly Conserved Allosteric Site on Their C-terminal Domains.","date":"2017","source":"ChemMedChem","url":"https://pubmed.ncbi.nlm.nih.gov/28371477","citation_count":39,"is_preprint":false},{"pmid":"29848507","id":"PMC_29848507","title":"The Calcium-Sensing Receptor Increases Activity of the Renal NCC through the WNK4-SPAK Pathway.","date":"2018","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/29848507","citation_count":38,"is_preprint":false},{"pmid":"11514053","id":"PMC_11514053","title":"Androgens induce expression of SPAK, a STE20/SPS1-related kinase, in LNCaP human prostate cancer cells.","date":"2001","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11514053","citation_count":37,"is_preprint":false},{"pmid":"24811174","id":"PMC_24811174","title":"A novel Ste20-related proline/alanine-rich kinase (SPAK)-independent pathway involving calcium-binding protein 39 (Cab39) and serine threonine kinase with no lysine member 4 (WNK4) in the activation of Na-K-Cl cotransporters.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24811174","citation_count":35,"is_preprint":false},{"pmid":"33500714","id":"PMC_33500714","title":"STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway.","date":"2021","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/33500714","citation_count":34,"is_preprint":false},{"pmid":"21088576","id":"PMC_21088576","title":"SPAK and WNK kinases: a new target for blood pressure treatment?","date":"2011","source":"Current opinion in nephrology and hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/21088576","citation_count":34,"is_preprint":false},{"pmid":"23235437","id":"PMC_23235437","title":"Enhanced FGF23 serum concentrations and phosphaturia in gene targeted mice expressing WNK-resistant SPAK.","date":"2012","source":"Kidney & blood pressure research","url":"https://pubmed.ncbi.nlm.nih.gov/23235437","citation_count":34,"is_preprint":false},{"pmid":"26861815","id":"PMC_26861815","title":"Deletion of the WNK3-SPAK kinase complex in mice improves radiographic and clinical outcomes in malignant cerebral edema after ischemic stroke.","date":"2016","source":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/26861815","citation_count":34,"is_preprint":false},{"pmid":"23044422","id":"PMC_23044422","title":"WNK-OSR1/SPAK-NCC signal cascade has circadian rhythm dependent on aldosterone.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23044422","citation_count":33,"is_preprint":false},{"pmid":"25994507","id":"PMC_25994507","title":"Critical role of the SPAK protein kinase CCT domain in controlling blood pressure.","date":"2015","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25994507","citation_count":32,"is_preprint":false},{"pmid":"23026752","id":"PMC_23026752","title":"The WNK/SPAK and IRBIT/PP1 pathways in epithelial fluid and electrolyte transport.","date":"2012","source":"Physiology (Bethesda, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/23026752","citation_count":31,"is_preprint":false},{"pmid":"23499375","id":"PMC_23499375","title":"Knockout of Ste20-like proline/alanine-rich kinase (SPAK) attenuates intestinal inflammation in mice.","date":"2013","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/23499375","citation_count":30,"is_preprint":false},{"pmid":"22415098","id":"PMC_22415098","title":"WNK3-SPAK interaction is required for the modulation of NCC and other members of the SLC12 family.","date":"2012","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22415098","citation_count":30,"is_preprint":false},{"pmid":"23427142","id":"PMC_23427142","title":"Loss of WNK3 is compensated for by the WNK1/SPAK axis in the kidney of the mouse.","date":"2013","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23427142","citation_count":30,"is_preprint":false},{"pmid":"18550547","id":"PMC_18550547","title":"PKCdelta acts upstream of SPAK in the activation of NKCC1 by hyperosmotic stress in human airway epithelial cells.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18550547","citation_count":29,"is_preprint":false},{"pmid":"22238094","id":"PMC_22238094","title":"Kinases SPAK and OSR1 are upregulated by estradiol and activate NKCC1 in the developing hypothalamus.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22238094","citation_count":28,"is_preprint":false},{"pmid":"32589890","id":"PMC_32589890","title":"Activated WNK3 induced by intracerebral hemorrhage deteriorates brain injury maybe via WNK3/SPAK/NKCC1 pathway.","date":"2020","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/32589890","citation_count":28,"is_preprint":false},{"pmid":"25531585","id":"PMC_25531585","title":"Negative regulation of the creatine transporter SLC6A8 by SPAK and OSR1.","date":"2014","source":"Kidney & blood pressure research","url":"https://pubmed.ncbi.nlm.nih.gov/25531585","citation_count":28,"is_preprint":false},{"pmid":"24808538","id":"PMC_24808538","title":"Novel mechanisms of Na+ retention in obesity: phosphorylation of NKCC2 and regulation of SPAK/OSR1 by AMPK.","date":"2014","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24808538","citation_count":27,"is_preprint":false},{"pmid":"32724175","id":"PMC_32724175","title":"WNK-SPAK/OSR1-NCC kinase signaling pathway as a novel target for the treatment of salt-sensitive hypertension.","date":"2020","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/32724175","citation_count":26,"is_preprint":false},{"pmid":"38353402","id":"PMC_38353402","title":"Modulation of Cerebrospinal Fluid Dysregulation via a SPAK and OSR1 Targeted Framework Nucleic Acid in Hydrocephalus.","date":"2024","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/38353402","citation_count":26,"is_preprint":false},{"pmid":"19343169","id":"PMC_19343169","title":"Ste20-related proline/alanine-rich kinase (SPAK) regulated transcriptionally by hyperosmolarity is involved in intestinal barrier function.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19343169","citation_count":26,"is_preprint":false},{"pmid":"28943960","id":"PMC_28943960","title":"STK39, overexpressed in osteosarcoma, regulates osteosarcoma cell invasion and proliferation.","date":"2017","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/28943960","citation_count":25,"is_preprint":false},{"pmid":"30723251","id":"PMC_30723251","title":"The interplay of renal potassium and sodium handling in blood pressure regulation: critical role of the WNK-SPAK-NCC pathway.","date":"2019","source":"Journal of human hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/30723251","citation_count":25,"is_preprint":false},{"pmid":"34374638","id":"PMC_34374638","title":"Knockdown of long non-coding RNA CDKN2B-AS1 suppresses the progression of breast cancer by miR-122-5p/STK39 axis.","date":"2021","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/34374638","citation_count":25,"is_preprint":false},{"pmid":"35413993","id":"PMC_35413993","title":"Role of SPAK-NKCC1 signaling cascade in the choroid plexus blood-CSF barrier damage after stroke.","date":"2022","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/35413993","citation_count":25,"is_preprint":false},{"pmid":"23527223","id":"PMC_23527223","title":"STK39 polymorphism is associated with essential hypertension: a systematic review and meta-analysis.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23527223","citation_count":24,"is_preprint":false},{"pmid":"31085334","id":"PMC_31085334","title":"Suppression of WNK1-SPAK/OSR1 Attenuates Bone Cancer Pain by Regulating NKCC1 and KCC2.","date":"2019","source":"The journal of pain","url":"https://pubmed.ncbi.nlm.nih.gov/31085334","citation_count":24,"is_preprint":false},{"pmid":"25323061","id":"PMC_25323061","title":"Regulation of ClC-2 activity by SPAK and OSR1.","date":"2014","source":"Kidney & blood pressure research","url":"https://pubmed.ncbi.nlm.nih.gov/25323061","citation_count":24,"is_preprint":false},{"pmid":"29923766","id":"PMC_29923766","title":"WNK-SPAK/OSR1 signaling: lessons learned from an insect renal epithelium.","date":"2018","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29923766","citation_count":23,"is_preprint":false},{"pmid":"25376088","id":"PMC_25376088","title":"SPAK dependent regulation of peptide transporters PEPT1 and PEPT2.","date":"2014","source":"Kidney & blood pressure research","url":"https://pubmed.ncbi.nlm.nih.gov/25376088","citation_count":23,"is_preprint":false},{"pmid":"25322850","id":"PMC_25322850","title":"SPAK and OSR1 dependent down-regulation of murine renal outer medullary K channel ROMK1.","date":"2014","source":"Kidney & blood pressure research","url":"https://pubmed.ncbi.nlm.nih.gov/25322850","citation_count":23,"is_preprint":false},{"pmid":"31786261","id":"PMC_31786261","title":"WNK4-SPAK modulates lipopolysaccharide-induced macrophage activation.","date":"2019","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31786261","citation_count":22,"is_preprint":false},{"pmid":"35272484","id":"PMC_35272484","title":"NF-κB Signaling-Mediated Activation of WNK-SPAK-NKCC1 Cascade in Worsened Stroke Outcomes of Ang II-Hypertensive Mice.","date":"2022","source":"Stroke","url":"https://pubmed.ncbi.nlm.nih.gov/35272484","citation_count":22,"is_preprint":false},{"pmid":"33719576","id":"PMC_33719576","title":"Roles of WNK4 and SPAK in K+-mediated dephosphorylation of the NaCl cotransporter.","date":"2021","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33719576","citation_count":21,"is_preprint":false},{"pmid":"25477470","id":"PMC_25477470","title":"STE20/SPS1-related proline/alanine-rich kinase (SPAK) is critical for sodium reabsorption in isolated, perfused thick ascending limb.","date":"2014","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25477470","citation_count":21,"is_preprint":false},{"pmid":"19717643","id":"PMC_19717643","title":"Epigenetic silencing of Stk39 in B-cell lymphoma inhibits apoptosis from genotoxic stress.","date":"2009","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19717643","citation_count":20,"is_preprint":false},{"pmid":"34335956","id":"PMC_34335956","title":"STK39 promotes breast cancer invasion and metastasis by increasing SNAI1 activity upon phosphorylation.","date":"2021","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/34335956","citation_count":19,"is_preprint":false},{"pmid":"35932362","id":"PMC_35932362","title":"MiR-223-3p-loaded exosomes from bronchoalveolar lavage fluid promote alveolar macrophage autophagy and reduce acute lung injury by inhibiting the expression of STK39.","date":"2022","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/35932362","citation_count":19,"is_preprint":false},{"pmid":"26208601","id":"PMC_26208601","title":"Domain-Swapping Switch Point in Ste20 Protein Kinase SPAK.","date":"2015","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26208601","citation_count":19,"is_preprint":false},{"pmid":"27519267","id":"PMC_27519267","title":"SPAK plays a pathogenic role in IgA nephropathy through the activation of NF-κB/MAPKs signaling pathway.","date":"2016","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27519267","citation_count":19,"is_preprint":false},{"pmid":"32413057","id":"PMC_32413057","title":"Staurosporine and NEM mainly impair WNK-SPAK/OSR1 mediated phosphorylation of KCC2 and NKCC1.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/32413057","citation_count":18,"is_preprint":false},{"pmid":"20006650","id":"PMC_20006650","title":"Behavioral analysis of Ste20 kinase SPAK knockout mice.","date":"2009","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/20006650","citation_count":18,"is_preprint":false},{"pmid":"29999233","id":"PMC_29999233","title":"The Photosensitising Clinical Agent Verteporfin Is an Inhibitor of SPAK and OSR1 Kinases.","date":"2018","source":"Chembiochem : a European journal of chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/29999233","citation_count":18,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":57042,"output_tokens":12085,"usd":0.176201,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":23132,"output_tokens":5881,"usd":0.131343,"stage2_stop_reason":"end_turn"},"total_usd":0.307544,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"SPAK is a serine/threonine kinase that autophosphorylates and phosphorylates exogenous substrates in vitro. Full-length SPAK localizes to the cytoplasm in transfected cells, while a caspase-cleaved form localizes predominantly to the nucleus. SPAK specifically activates the p38 MAPK pathway in cotransfection assays.\",\n      \"method\": \"In vitro kinase assay, immunofluorescence localization, cotransfection reporter assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — in vitro kinase assay and localization data from single lab, no replication\",\n      \"pmids\": [\"10980603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"SPAK physically interacts with the cation-chloride cotransporters NKCC1, NKCC2, and KCC3 (but not KCC1 or KCC4) via an (R/K)FX(V/I)-containing motif on the cotransporters and the C-terminal 100 amino acids of SPAK. In vivo co-immunoprecipitation of SPAK from mouse brain with anti-NKCC1 antibody was confirmed. SPAK co-localizes with NKCC1 on the apical membrane of choroid plexus epithelium; in NKCC1-null mice, SPAK redistributes to the cytoplasm.\",\n      \"method\": \"Yeast two-hybrid, GST pulldown, co-immunoprecipitation, immunohistochemistry\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (Y2H, pulldown, co-IP, IHC), replicated binding motif finding\",\n      \"pmids\": [\"12386165\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"SPAK binding to NKCC1 is not required for basal cotransporter activity (NKCC1 mutant lacking SPAK binding showed identical K+ transport to wild-type). However, SPAK co-immunoprecipitates with p38 MAPK and NKCC1 in an activity-dependent manner; cellular stress reduces the amount of p38 co-immunoprecipitated with SPAK/NKCC1, while the SPAK-NKCC1 interaction remains unchanged, suggesting a scaffolding role for SPAK.\",\n      \"method\": \"86Rb+ uptake functional assay in Xenopus oocytes, co-immunoprecipitation, Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional assay plus reciprocal co-IP, single lab with two orthogonal methods\",\n      \"pmids\": [\"14563843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"SPAK is a substrate and binding partner of PKCθ. PKCθ phosphorylates SPAK at Ser311 in the kinase domain. TCR/CD28 costimulation enhances SPAK-PKCθ association and SPAK kinase activity. SPAK synergizes with constitutively active PKCθ to activate AP-1 (but not NF-κB); dominant-negative SPAK or SPAK RNAi inhibits PKCθ- and TCR/CD28-induced AP-1 activation.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, site-directed mutagenesis (S311 mutation), RNAi knockdown, reporter assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct phosphorylation demonstrated in vitro with mutagenesis validation plus functional epistasis in cells, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"14988727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"WNK1 co-immunoprecipitates with SPAK from rat testis. WNK1 and WNK4 both phosphorylate SPAK at Thr233 (T-loop) and Ser373 (C-terminal non-catalytic region). Phosphorylation of Thr233 (equivalent to Thr185 in OSR1) by WNK1 is required for SPAK activation; T-loop mutation to Ala abolishes activation, while Glu mutation (phosphomimetic) constitutively activates the kinase.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, phosphopeptide mapping, site-directed mutagenesis\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro phosphorylation with mutagenesis and phosphopeptide mapping; independently replicated in multiple labs\",\n      \"pmids\": [\"16083423\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"WNK1 phosphorylates SPAK and OSR1, activating them. SPAK and OSR1 directly phosphorylate the N-terminal regulatory regions of cation-chloride cotransporters NKCC1, NKCC2, and NCC. Hypotonic stress activates SPAK/OSR1 and induces NCC phosphorylation in cells.\",\n      \"method\": \"In vitro kinase assay, cell-based phosphorylation assay, Xenopus oocyte expression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with direct phosphorylation, independently replicated\",\n      \"pmids\": [\"16263722\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SPAK phosphorylates NKCC1 at Thr203/Thr207/Thr212 (human). The conserved C-terminal CCT domain of SPAK interacts with an RFXV motif present in both its substrate NKCC1 and its activators WNK1/WNK4; this docking interaction is required for efficient phosphorylation of NKCC1 but not of a peptide substrate lacking the RFXV motif. Mutation of specific CCT domain residues abolishes RFXV binding and prevents NKCC1 phosphorylation.\",\n      \"method\": \"In vitro kinase assay, peptide affinity purification, site-directed mutagenesis, osmotic stress cell assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution, mutagenesis of both kinase and substrate, multiple orthogonal approaches, single rigorous study\",\n      \"pmids\": [\"16669787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Mutation of SPAK activation loop residues Thr243 or Thr247 to Ala prevents WNK4-mediated activation and robustly inhibits NKCC1 cotransporter activity in Xenopus oocytes. SPAK activity is inhibited by staurosporine and K252a. OSR1 exhibits similar kinase properties and functional activation of NKCC1 when coexpressed with WNK4.\",\n      \"method\": \"Site-directed mutagenesis, 86Rb+ uptake functional assay in Xenopus oocytes, in vitro kinase assay with Mn2+/Mg2+\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis of activation loop combined with functional cotransporter assay, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"16382158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Physical docking of SPAK to NKCC1 via a single RFXV-containing binding motif (mutation of the Phe residue abrogates both binding and function) is necessary for NKCC1 activation under basal and hyperosmotic conditions. SPAK docking to NKCC1 is required for efficient phosphorylation of NKCC1 at Thr206 and Thr211.\",\n      \"method\": \"Yeast two-hybrid, in vitro 32P-phosphorylation, 86Rb+ uptake assay in Xenopus oocytes, site-directed mutagenesis\",\n      \"journal\": \"Cellular physiology and biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution with mutagenesis and functional readout, multiple orthogonal methods in single lab\",\n      \"pmids\": [\"17595523\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"SPAK interacts with apoptosis-associated tyrosine kinase (AATYK1) via RFXV-like binding motifs on AATYK1; disruption of these motifs abrogates AATYK1-mediated inhibition of NKCC1. AATYK1 also scaffolds protein phosphatase 1 (PP1) via a PP1-docking motif; this interaction is required for NKCC1 inhibition, suggesting AATYK1 indirectly inhibits SPAK/WNK4 activation of NKCC1 by bringing PP1 into proximity.\",\n      \"method\": \"Xenopus oocyte functional assay, yeast two-hybrid, site-directed mutagenesis\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional assay and Y2H with mutagenesis, single lab\",\n      \"pmids\": [\"17267545\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"SPAK and OSR1 kinases activated by WNK1 phosphorylate human NCC at Thr46, Thr55, and Thr60. Efficient NCC phosphorylation requires docking via an RFXI motif on NCC. Mutation of Thr60 to Ala markedly inhibits phosphorylation of Thr46 and Thr55 and NCC activation. Hypotonic low-chloride conditions in HEK293 or mpkDCT cells induce SPAK/OSR1-dependent phosphorylation of NCC.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis, cell-based phosphorylation assay (HEK293 and mpkDCT cells)\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro phosphorylation with mutagenesis, confirmed in cell-based system, independently replicated\",\n      \"pmids\": [\"18270262\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"STK39/SPAK is expressed in the distal nephron in vivo and interacts with WNK kinases and cation-chloride cotransporters in cell-based functional studies. An intronic element with allele-specific transcription activity was identified as a functional candidate for BP association, suggesting variants increase STK39 expression to alter renal Na+ excretion.\",\n      \"method\": \"In vivo expression analysis (immunohistochemistry), cell-based functional assay (co-interaction studies), reporter assay for allele-specific transcription\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — functional reporter assay and localization data, interaction confirmed in cell-based system\",\n      \"pmids\": [\"19114657\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PKCδ directly binds SPAK, phosphorylates and activates it upstream of NKCC1 in human airway epithelial cells during hyperosmotic stress. SPAK siRNA knockdown prevents NKCC1 phosphorylation and functional activation. GST pulldown confirms direct SPAK-NKCC1 interaction; a NKCC1 N-terminal peptide competitively inhibits SPAK-NKCC1 binding.\",\n      \"method\": \"RNAi knockdown, 86Rb+ flux assay, GST pulldown, recombinant protein kinase assay, competitive peptide inhibition\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct binding and kinase assays with functional validation by siRNA knockdown, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"18550547\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"WNK3 activates NKCC2 through SPAK in a chloride-sensing mechanism; intracellular Cl- depletion activates NKCC2 by promoting phosphorylation at Thr96, Thr101, and Thr111. WNK3 is positioned upstream of SPAK; elimination of WNK3's SPAK-binding motif prevents NKCC2 activation. SPAK is required for chloride-sensitive NKCC2 activation.\",\n      \"method\": \"Xenopus oocyte expression, site-directed mutagenesis, epistasis analysis with dominant-negative constructs\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with mutagenesis in functional oocyte system, single lab with multiple constructs\",\n      \"pmids\": [\"18550832\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"AngII signaling increases NCC activity through a WNK4-SPAK-dependent pathway; dominant-negative SPAK or elimination of the SPAK binding motif on NCC prevents AngII-mediated NCC activation. AngII increases phosphorylation of SPAK and NCC at residues required for their activation in mpkDCT cells.\",\n      \"method\": \"Xenopus oocyte functional assay, dominant-negative SPAK constructs, mpkDCT cell phosphorylation assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis with dominant-negative and motif-mutant constructs in two independent systems, single lab\",\n      \"pmids\": [\"19240212\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SPAK silencing by shRNA in B cells protects against caspase-dependent apoptosis induced by DNA double-strand breaks but not from osmotic/oxidative stress-induced apoptosis. Caspase 3 cleavage is impaired upon SPAK repression in DNA-damaged B cells, implicating SPAK in a JNK-dependent apoptosis pathway.\",\n      \"method\": \"shRNA knockdown, caspase 3 cleavage assay, apoptosis assays, pharmacological JNK inhibition\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — functional knockdown with specific apoptosis readout, single lab\",\n      \"pmids\": [\"19717643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SPAK knockout mice exhibit higher nociceptive thresholds, locomotor deficits (rotarod and open-field), and increased anxiety-like behavior, indicating SPAK plays an important role in CNS function consistent with regulating ion transport mechanisms involved in inhibitory neurotransmission.\",\n      \"method\": \"SPAK knockout mouse behavioral analysis (hot plate, tail flick, rotarod, open-field, light/dark box)\",\n      \"journal\": \"Behavioural brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — clean knockout with defined behavioral phenotype, single lab\",\n      \"pmids\": [\"20006650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SPAK-null mice display Gitelman syndrome phenotype (hypotension, hypokalemia, hypomagnesemia, hypocalciuria) with markedly decreased total and phosphorylated NCC in kidney, but increased p-OSR1 and p-NKCC2. In aortic tissue, NKCC1 expression increased but p-NKCC1 decreased. SPAK-null mice had impaired contractile responses to phenylephrine and bumetanide, indicating SPAK regulates both renal NCC and vascular NKCC1.\",\n      \"method\": \"Targeted gene disruption (exons 9-10), blood pressure measurement, plasma electrolytes, diuretic challenges, phospho-specific Western blot, vascular contractility assay\",\n      \"journal\": \"Journal of the American Society of Nephrology : JASN\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout mouse with comprehensive phenotyping including phospho-specific readouts and functional vascular assays\",\n      \"pmids\": [\"20813865\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SPAK knock-in mice in which SPAK cannot be activated by WNKs display significantly reduced blood pressure (salt-dependent) and markedly reduced phosphorylation of NCC and NKCC2 at SPAK-targeted residues, as well as reduced NCC and NKCC2 protein expression without mRNA changes.\",\n      \"method\": \"Knock-in mouse model (WNK-resistant SPAK), blood pressure telemetry, phospho-specific Western blot, qPCR\",\n      \"journal\": \"EMBO molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knock-in with mechanistic phosphorylation readout, replicated across multiple labs\",\n      \"pmids\": [\"20091762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PP1 directly dephosphorylates both NKCC1 and SPAK in vitro. PP1 dephosphorylation of SPAK is markedly enhanced when SPAK is scaffolded to the NKCC1 N-terminal tail; mutation of the PP1 binding motif in NKCC1 reduces PP1 inhibitory effect. The N-terminal tail of NKCC1 thus serves as a regulatory scaffold for both SPAK and PP1.\",\n      \"method\": \"In vitro dephosphorylation assay, Xenopus oocyte functional assay, site-directed mutagenesis of PP1 docking motif\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with mutagenesis and functional oocyte system, single lab\",\n      \"pmids\": [\"20223824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SPAK substrate recognition requires two threonine residues in NKCC1 separated by four amino acids; addition or removal of a single residue abrogates SPAK-mediated NKCC1 activation. Constitutively active SPAK is created by T243E/S383D double mutation or by S383A mutation alone (which removes autoinhibition). WNK4 can phosphorylate SPAK at S321 in a deletion mutant.\",\n      \"method\": \"Site-directed mutagenesis, Xenopus oocyte 86Rb+ uptake assay\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — systematic mutagenesis with functional assay, single lab\",\n      \"pmids\": [\"20463172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SORLA (an intracellular sorting receptor) interacts with SPAK and controls its intracellular trafficking; SORLA deficiency leads to SPAK missorting, inability to phosphorylate NKCC2, and impaired renal sodium reabsorption under osmotic stress.\",\n      \"method\": \"Co-immunoprecipitation, SORLA knockout mouse model, phospho-specific Western blot, immunofluorescence\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus knockout phenotype with phosphorylation readout, single lab\",\n      \"pmids\": [\"20385770\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"A kidney-specific SPAK isoform lacking the kinase domain inhibits phosphorylation of NCC and NKCC2 by full-length SPAK in vitro. Kidney-specific SPAK is highly expressed in the thick ascending limb (TAL), while full-length SPAK predominates in the distal convoluted tubule (DCT). SPAK knockout has divergent nephron-segment-specific effects: increased p-NKCC2 in TAL but decreased p-NCC in DCT.\",\n      \"method\": \"In vitro kinase assay, SPAK knockout mouse analysis, nephron segment-specific expression analysis, phospho-specific Western blot\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro inhibition assay plus knockout phenotyping with segment-specific analysis, single lab\",\n      \"pmids\": [\"21907141\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"MO25α/β bind to SPAK and OSR1 and induce ~100-fold activation of their kinase activity, dramatically enhancing their ability to phosphorylate NKCC1, NKCC2, and NCC. siRNA knockdown of MO25 in mammalian cells inhibits endogenous NKCC1 phosphorylation at SPAK/OSR1-targeted residues, rescued by MO25α re-expression.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, siRNA knockdown, MS identification of new phosphorylation sites\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro activation assay with dramatic effect plus siRNA rescue experiment, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"21423148\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"WNK kinases act as scaffolds to recruit SPAK to the complex with CFTR and NBCe1-B in pancreatic ductal epithelia; SPAK phosphorylates CFTR and NBCe1-B, reducing their cell surface expression. IRBIT opposes WNK/SPAK by recruiting PP1 to dephosphorylate CFTR and NBCe1-B, restoring surface expression. Silencing SPAK and IRBIT together rescues ductal secretion lost from IRBIT silencing alone.\",\n      \"method\": \"siRNA knockdown (SPAK, WNK, IRBIT), epithelial secretion assay, surface expression analysis, epistasis rescue experiment\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis demonstrated by double-knockdown rescue, functional secretion readout, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"21317537\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"SPAK directly phosphorylates NKCC2 isoforms at Thr95, Thr100, and Thr105 (and possibly Ser91) through docking at an RFQV motif on NKCC2. Hypotonic low-chloride conditions activate WNK1-SPAK/OSR1 pathway to phosphorylate NKCC2. In contrast to NCC, NKCC2 is constitutively at the membrane and not translocated by SPAK/OSR1 phosphorylation.\",\n      \"method\": \"In vitro kinase assay, cell-based phosphorylation assay, mutagenesis of RFQV motif\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro phosphorylation with docking motif mutagenesis, confirmed in cellular system\",\n      \"pmids\": [\"21321328\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NKCC1 is not phosphorylated or activated in SPAK/OSR1 double-knockin embryonic stem cells where both kinases cannot be activated by WNK1, establishing that SPAK and OSR1 are the essential intermediaries for WNK1-dependent NKCC1 phosphorylation. These knockin cells also exhibit markedly elevated WNK1 and WNK3 activity, revealing a feedback whereby SPAK/OSR1 suppresses WNK activity.\",\n      \"method\": \"Double-knockin ES cells, NKCC1 phosphorylation assay, WNK kinase activity measurement\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis using double-knockin cells, independently replicated finding\",\n      \"pmids\": [\"22032326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SPAK and OSR1 co-localize with MO25α at the apical membrane of TAL and DCT. In SPAK-null mice DCT (but not TAL), OSR1 becomes largely inactive, displaced from MO25α and NCC at the apical membrane, and redistributes to dense punctate cytoplasmic structures with WNK1, resulting in decreased NCC phosphorylation and reduced DCT mass.\",\n      \"method\": \"SPAK knockout mouse analysis, co-localization immunofluorescence, phospho-specific Western blot, nephron morphometry\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockout mouse with subcellular localization and functional phosphorylation readouts, single lab with multiple methods\",\n      \"pmids\": [\"22977235\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SPAK and OSR1 kinases phosphorylate and activate NKCC1 in the developing hypothalamus. Estradiol increases SPAK and OSR1 protein levels via transcription-dependent mechanisms. Antisense knockdown of SPAK (and to a lesser degree OSR1) precludes estradiol-mediated NKCC1 phosphorylation enhancement and diminishes GABA-induced Ca2+ influx.\",\n      \"method\": \"Antisense oligonucleotide knockdown, Western blot, Ca2+ imaging in embryonic hypothalamic cultures\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — antisense knockdown with phosphorylation and functional calcium readout, single lab\",\n      \"pmids\": [\"22238094\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SPAK phosphorylation at S383 by WNK and p-NKCC2/p-NCC show diurnal rhythms in mouse kidney dependent on aldosterone; spironolactone treatment attenuates phosphorylation and diminishes this diurnal pattern, and exogenous aldosterone restores it.\",\n      \"method\": \"Time-course Western blot with phospho-specific antibodies, mineralocorticoid receptor antagonist treatment\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — in vivo pharmacological manipulation with phospho-specific readout, single lab\",\n      \"pmids\": [\"23044422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The PI3K/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC cascade in hyperinsulinemic db/db mice. In SpakT243A/+ and Osr1T185A/+ knock-in db/db mice (preventing WNK-mediated activation), increased NCC phosphorylation and elevated blood pressure are completely corrected, establishing that WNK phosphorylation of SPAK/OSR1 T-loop is required for insulin/PI3K-mediated NCC activation.\",\n      \"method\": \"Knock-in mouse epistasis (T243A/T185A preventing WNK activation), PI3K/Akt inhibitor treatment, phospho-specific Western blot\",\n      \"journal\": \"Hypertension\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis using knock-in mice combined with pharmacological inhibitors, comprehensive phenotyping\",\n      \"pmids\": [\"22949526\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SPAK interacts with and phosphorylates NBCe1-B at Ser65; phosphorylation of Thr49 is required for regulation by both IRBIT and SPAK. SPAK-dependent phosphorylation of NBCe1-B and NBCn1-A is mediated through a conserved positively-charged regulatory module within residues 37-65 of NBCe1-B.\",\n      \"method\": \"Co-immunoprecipitation, mutagenesis, functional transporter assay, phospho-site identification\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis with functional transporter assay and phospho-site mapping, single lab\",\n      \"pmids\": [\"23431199\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Aldosterone acutely stimulates SPAK phosphorylation (requiring mineralocorticoid receptor and SGK1); gene silencing of SPAK eliminates aldosterone-induced NCC activity and phosphorylation. Aldosterone effects on NCC activity are SPAK-dependent.\",\n      \"method\": \"siRNA knockdown of SPAK, NCC activity assay, phospho-specific Western blot, adrenalectomized rodent model with aldosterone infusion\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown with functional NCC activity readout and in vivo confirmation, single lab\",\n      \"pmids\": [\"23739593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SPAK-deficient mice exhibit significantly increased intestinal transepithelial resistance, decreased paracellular permeability, and altered tight junction protein expression (decreased claudin-2; increased occludin, E-cadherin, β-catenin, claudin-5). SPAK-null mice are more tolerant to DSS- and TNBS-induced colitis with increased IL-10 and decreased proinflammatory cytokines.\",\n      \"method\": \"SPAK knockout mouse analysis, transepithelial resistance measurement, permeability assay, tight junction protein expression, colitis models\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean knockout with multiple defined readouts for epithelial barrier function, single lab\",\n      \"pmids\": [\"23499375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SPAK and OSR1 (with MO25 regulatory subunit) directly phosphorylate all KCC isoforms at a conserved C-terminal Thr residue (Site-2, Thr1048 in KCC3A), inhibiting KCC activity. In ES cells lacking SPAK/OSR1 activity, KCC Site-2 phosphorylation is abolished and KCC3A activity is elevated. A Site-2 Ala KCC3A mutant (preventing SPAK/OSR1 phosphorylation) exhibits increased activity. Thus SPAK/OSR1 coordinate reciprocal actions: stimulating NKCCs (Cl- influx) and inhibiting KCCs (Cl- efflux).\",\n      \"method\": \"In vitro kinase assay with MO25, SPAK/OSR1 double-knockin ES cells, 86Rb+ uptake assay, site-directed mutagenesis, pathway inhibitor STOCK1S-50699\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with mutagenesis, genetic ES cell model, and functional transport assay; multiple orthogonal approaches in single comprehensive study\",\n      \"pmids\": [\"24393035\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The SPAK CCT domain Leu502 residue is critical for high-affinity recognition of RFXI/V motifs in WNK1, NCC, and NKCC2; Leu502Ala knock-in mice show abolished co-immunoprecipitation of SPAK with WNK1/NCC/NKCC2, markedly reduced SPAK activity, and reduced phosphorylation and expression of NCC and NKCC2, causing Gitelman syndrome-like phenotype.\",\n      \"method\": \"Knock-in mouse model (L502A), co-immunoprecipitation, phospho-specific Western blot, blood pressure measurement, electrolyte analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knock-in mouse model with direct biochemical validation (co-IP abolished by mutation), replicated functional consequences\",\n      \"pmids\": [\"25994507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SPAK is important for endothelial cell proliferation (distinct from OSR1, which is required for chemotaxis/invasion) in WNK1-dependent angiogenic signaling. In HUVECs, SPAK mediates WNK1-dependent cord formation through effects on cell proliferation.\",\n      \"method\": \"HUVEC siRNA knockdown, cord formation assay, proliferation assay, chemotaxis/invasion assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown with multiple functional readouts distinguishing SPAK from OSR1, single lab\",\n      \"pmids\": [\"25362046\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Crystal structures of SPAK kinase domain (residues 63-403, at 3.1 Å) and SPAK 63-390 T243D (at 2.5 Å) reveal domain-swapped dimer architecture. The T243D activating mutation induces significant conformational changes but retains some inactive features. A monomeric SPAK mutant retains kinase activity and can be activated by WNK1 but has reduced phosphorylation of NKCC2, indicating domain swapping has regulatory roles.\",\n      \"method\": \"X-ray crystallography, site-directed mutagenesis to create monomeric mutant, in vitro kinase assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structures at defined resolution combined with mutagenesis and functional validation, single rigorous study\",\n      \"pmids\": [\"26208601\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ASK3 (apoptosis signal-regulating kinase 3) interacts with WNK1 and suppresses the WNK1-SPAK/OSR1 signaling pathway. ASK3 knockdown by siRNA enhances WNK1-SPAK/OSR1 activation; ASK3 knockout mice exhibit hypertensive phenotype with hyperactivation of SPAK/OSR1 in renal tubules.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, ASK3 knockout mouse model, phospho-specific Western blot, blood pressure measurement\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus knockout mouse epistasis with phosphorylation readout, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"23250415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Constitutively active SPAK (kinase-activating mutation in Stk39 expressed DCT-specifically via Cre) causes NCC hyperphosphorylation, thiazide-treatable hypertension, and hyperkalemia. Additionally, CA-SPAK mice exhibit ASDN remodeling: reduced connecting tubule mass, attenuation of ENaC and ROMK expression and apical localization. Blocking NCC with thiazide gradually restores ASDN structure and K+ excretion.\",\n      \"method\": \"Conditional knock-in mouse (lox-P flanked CA-SPAK, DCT Cre), blood pressure telemetry, thiazide challenge, phospho-specific IHC and Western blot, urinary electrolytes\",\n      \"journal\": \"Journal of the American Society of Nephrology : JASN\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional constitutively active knock-in model with comprehensive phenotyping and pharmacological rescue\",\n      \"pmids\": [\"28442491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Rafoxanide binds an allosteric pocket on the SPAK C-terminal (CCT) domain and inhibits SPAK and OSR1 activity in an ATP-independent manner.\",\n      \"method\": \"In silico screening, biochemical binding assay, in vitro kinase inhibition assay\",\n      \"journal\": \"ChemMedChem\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — binding and inhibition demonstrated biochemically; allosteric site identification, single lab\",\n      \"pmids\": [\"28371477\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Verteporfin binds the kinase domain of SPAK and OSR1 and inhibits their catalytic activity in an ATP-independent manner. In cells, verteporfin suppresses SPAK/OSR1-dependent phosphorylation of NKCC1.\",\n      \"method\": \"Binding assay, in vitro kinase assay, cell-based NKCC1 phosphorylation assay\",\n      \"journal\": \"Chembiochem\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — biochemical binding and in vitro inhibition confirmed in cellular system, single lab\",\n      \"pmids\": [\"29999233\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"WNK bodies in the distal convoluted tubule contain phosphorylated SPAK/OSR1 under K+-deprived conditions. In WNK4-deficient mice, WNK bodies still form but contain unphosphorylated SPAK/OSR1, indicating WNK4 is the primary active kinase catalyzing SPAK/OSR1 phosphorylation within WNK bodies.\",\n      \"method\": \"Immunofluorescence microscopy in dietary K+ manipulation mouse models, WNK4-deficient and Kir4.1-deficient mice\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo localization with genetic epistasis using multiple knockout/deficient lines, single lab\",\n      \"pmids\": [\"31736353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"ZT-1a, a selective SPAK inhibitor, decreases SPAK-dependent phosphorylation of NKCC1 and increases KCC-mediated Cl- efflux in brain. Intracerebroventricular ZT-1a reduces CSF hypersecretion in post-hemorrhagic hydrocephalus model; systemic ZT-1a reduces ischemia-induced CCC phosphorylation, attenuates cerebral edema, and improves stroke outcomes.\",\n      \"method\": \"Selective SPAK inhibitor (ZT-1a) treatment in rodent models of hydrocephalus and stroke, CCC phosphorylation assay, brain water content, neurological scoring\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological inhibition with mechanistic phosphorylation readout in two disease models, single lab with multiple orthogonal readouts\",\n      \"pmids\": [\"31911626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"STK39/SPAK interacts with PLK1 by mass spectrometry; STK39 promotes HCC progression and activates ERK signaling in a PLK1-dependent manner. STK39 knockdown causes G2/M cell cycle arrest and apoptosis in HCC cells; overexpression promotes proliferation, migration, and invasion.\",\n      \"method\": \"Mass spectrometry, co-immunoprecipitation, RNA-seq pathway analysis, gain/loss-of-function assays in HCC cells\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — MS-identified interaction and epistasis (PLK1-dependent ERK activation) with functional knockdown/OE, single lab\",\n      \"pmids\": [\"33500714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"STK39 directly phosphorylates SNAI1 at Thr203, which is critical for SNAI1 nuclear retention and stability. STK39 inhibition or knockdown destabilizes SNAI1, impairs EMT, and decreases tumor cell migration, invasion, and metastasis in vitro and in vivo; effects are rescued by ectopic SNAI1 expression.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay with phospho-site mutagenesis (T203), subcellular fractionation, loss-of-function assays, xenograft rescue experiment\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct phosphorylation of SNAI1 at defined site with mutagenesis validation and functional rescue in vivo, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"34335956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"High extracellular K+ rapidly dephosphorylates SPAK in vitro (HEK293 cells) and ex vivo (kidney slices), causing dissolution of SPAK puncta in DCT1 in vivo. The WNK4-SPAK 'on' switch must be turned off for rapid NCC dephosphorylation by high K+; longer-term WNK-SPAK stimulation attenuates sensitivity to rapid K+-induced NCC dephosphorylation. Neither PP1 nor PP3 alone or together is essential for rapid NCC dephosphorylation.\",\n      \"method\": \"In vitro kinase/phosphatase assay in HEK293 cells, ex vivo kidney slice, in vivo dietary K+ challenge with immunofluorescence and Western blot, phosphatase inhibitor experiments\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple experimental systems (in vitro, ex vivo, in vivo) with pharmacological dissection, single lab\",\n      \"pmids\": [\"33719576\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"STK39/SPAK is a STE20-family serine/threonine kinase that is activated by WNK kinases (primarily WNK1, WNK3, and WNK4) through phosphorylation of its T-loop Thr243 by WNKs; once activated (further stimulated ~100-fold by the co-activator MO25), SPAK directly phosphorylates and stimulates Na+-driven cation-chloride cotransporters (NKCC1, NKCC2, NCC) while also directly phosphorylating and inhibiting K+-driven KCCs—coordinated reciprocal actions that increase net intracellular Cl- and maintain ionic homeostasis; this docking-dependent mechanism requires the conserved CCT domain of SPAK to recognize RFXV/I motifs on both upstream WNK activators and downstream cotransporter substrates; SPAK also participates in stress signaling (activating p38 and JNK via RELT and PKCθ-AP-1 pathways), regulates epithelial secretion by phosphorylating CFTR and NBCe1-B, phosphorylates SNAI1 at Thr203 to promote nuclear retention and EMT, and in vivo is essential for renal salt reabsorption, blood pressure regulation, and normal CNS function.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"STK39/SPAK is a STE20-family serine/threonine kinase that functions as the central effector linking WNK kinase signaling to ion cotransporter regulation, thereby controlling intracellular chloride homeostasis, renal salt reabsorption, and blood pressure [#5, #18]. SPAK is activated when WNK kinases (WNK1, WNK3, WNK4) phosphorylate its T-loop threonine (Thr233/Thr243), a modification required for catalytic activation and further amplified ~100-fold by the co-activator MO25 [#4, #23]. SPAK recognizes both its upstream activators and downstream substrates through its conserved C-terminal CCT domain, which docks onto RFX(V/I) motifs; the Leu502 residue of this domain is critical for high-affinity binding, and disrupting docking abolishes substrate phosphorylation in vitro and in vivo [#6, #35]. Through this docking-dependent mechanism SPAK directly phosphorylates the N-terminal regulatory regions of the Na+-driven cotransporters NKCC1, NKCC2, and NCC to stimulate Cl- influx, while phosphorylating a conserved C-terminal site on the K+-driven KCCs to inhibit them, executing coordinated reciprocal control of net intracellular chloride [#5, #25, #34]. In vivo this axis is essential for distal nephron NCC/NKCC2 function: loss of SPAK or its WNK-mediated activation produces Gitelman-syndrome-like salt wasting and hypotension, whereas constitutive SPAK activation drives thiazide-treatable hypertension and hyperkalemia [#17, #18, #39]. The pathway integrates hormonal and physiological inputs including angiotensin II, aldosterone, and insulin/PI3K signaling, and SPAK activity is opposed by phosphatase recruitment (PP1 scaffolded via cotransporter tails) and by upstream regulators such as ASK3 [#14, #30, #19, #38]. Beyond ion transport, SPAK contributes to stress and immune signaling—activating p38 and synergizing with PKCθ to drive AP-1 [#0, #3]—regulates epithelial secretion by phosphorylating CFTR and NBCe1-B [#24, #31], and in cancer promotes EMT and metastasis by directly phosphorylating SNAI1 at Thr203 to stabilize it [#45].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Established SPAK as a catalytically active serine/threonine kinase and first linked it to stress MAPK signaling, defining its enzymatic identity before any transport role was known.\",\n      \"evidence\": \"In vitro kinase assay, immunofluorescence, and cotransfection reporter assay\",\n      \"pmids\": [\"10980603\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No physiological substrate identified\", \"Caspase-cleaved nuclear form's function unresolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identified the cation-chloride cotransporters as physical SPAK partners and defined the (R/K)FX(V/I)-docking motif, establishing the molecular basis for substrate recognition.\",\n      \"evidence\": \"Yeast two-hybrid, GST pulldown, co-IP from brain, and choroid plexus immunohistochemistry\",\n      \"pmids\": [\"12386165\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding alone did not establish a catalytic/regulatory consequence\", \"Upstream activator of SPAK still unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showed SPAK can act as an activity-dependent scaffold linking p38 to NKCC1 rather than a direct transport regulator, raising the question of how SPAK actually controls cotransporter function.\",\n      \"evidence\": \"86Rb+ uptake in Xenopus oocytes and reciprocal co-IP\",\n      \"pmids\": [\"14563843\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not resolve whether SPAK phosphorylates the cotransporter\", \"Scaffolding vs catalytic roles not separated\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Placed SPAK in T-cell receptor signaling as a PKCθ substrate driving AP-1, expanding its role beyond transport into immune stress signaling.\",\n      \"evidence\": \"Co-IP, in vitro kinase assay, S311 mutagenesis, RNAi, and reporter assays\",\n      \"pmids\": [\"14988727\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct AP-1-relevant substrate of SPAK not identified\", \"Relationship to transport functions unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identified WNK kinases as the upstream activators that phosphorylate the SPAK T-loop, and showed SPAK directly phosphorylates NKCC1/NKCC2/NCC, defining the core WNK–SPAK–cotransporter cascade.\",\n      \"evidence\": \"Co-IP, in vitro kinase assays, phosphopeptide mapping, T-loop mutagenesis, and oocyte expression\",\n      \"pmids\": [\"16083423\", \"16263722\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Docking requirement for efficient phosphorylation not yet mechanistically defined\", \"Physiological stimulus integration unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined the CCT-domain/RFXV docking mechanism and the activation-loop threonines as jointly required for substrate phosphorylation and cotransporter activation, unifying recognition and catalysis.\",\n      \"evidence\": \"In vitro kinase assays, peptide affinity purification, and activation-loop/CCT mutagenesis with oocyte transport assays\",\n      \"pmids\": [\"16669787\", \"16382158\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of docking not yet visualized\", \"Quantitative contribution of docking to in vivo regulation unaddressed\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Extended the cascade to NCC and NKCC2 with defined phospho-sites and docking motifs, and identified additional upstream activating kinases (PKCδ) and a Cl--sensing WNK3 input, mapping how the pathway integrates osmotic/ionic stress.\",\n      \"evidence\": \"In vitro kinase assays, RNAi, GST pulldown, and oocyte functional assays with motif mutagenesis\",\n      \"pmids\": [\"18270262\", \"18550547\", \"18550832\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of chloride sensing not fully resolved\", \"Cross-talk between PKC and WNK activation inputs unclear\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Connected SPAK genetic variation to blood pressure and demonstrated hormonal (angiotensin II) input, linking the molecular cascade to human cardiovascular physiology.\",\n      \"evidence\": \"Allele-specific reporter assay, immunohistochemistry, and AngII oocyte/mpkDCT epistasis with dominant-negative SPAK\",\n      \"pmids\": [\"19114657\", \"19240212\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal variant mechanism on expression incompletely defined\", \"AngII-to-SPAK signaling intermediates unmapped\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Established SPAK as physiologically essential for renal NCC/NKCC2 regulation and blood pressure via knockout and WNK-resistant knock-in mice, and defined opposing PP1 dephosphorylation and SORLA-dependent trafficking that tune the pathway.\",\n      \"evidence\": \"Knockout and knock-in mouse phenotyping with phospho-specific Westerns, in vitro PP1 dephosphorylation, and SORLA co-IP/knockout\",\n      \"pmids\": [\"20813865\", \"20091762\", \"20223824\", \"20385770\", \"20463172\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphatase identity for in vivo dephosphorylation not fully resolved\", \"Nephron-segment-specific divergence not yet explained\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identified MO25 as the ~100-fold co-activator, resolved nephron-segment-specific regulation via a kinase-dead kidney SPAK isoform, and extended SPAK to epithelial secretion (CFTR/NBCe1-B) and angiogenesis.\",\n      \"evidence\": \"In vitro activation assays, siRNA rescue, segment-specific knockout analysis, secretion/epistasis assays, and HUVEC functional assays\",\n      \"pmids\": [\"21423148\", \"21907141\", \"21317537\", \"21321328\", \"25362046\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Regulation balancing full-length vs kinase-dead isoforms unclear\", \"Mechanism of SPAK in proliferation distinct from transport undefined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Proved genetically (SPAK/OSR1 double-knockin ES cells) that SPAK/OSR1 are obligatory intermediaries for WNK1-dependent NKCC1 phosphorylation and revealed feedback suppression of WNK activity, plus aldosterone/insulin hormonal control of the axis.\",\n      \"evidence\": \"Double-knockin ES cells, knockout mouse localization, knock-in epistasis with PI3K inhibitors, and aldosterone time-course Westerns\",\n      \"pmids\": [\"22032326\", \"22977235\", \"22238094\", \"23044422\", \"22949526\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of SPAK/OSR1-to-WNK feedback unresolved\", \"Integration of multiple hormonal inputs at the kinase level unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defined SPAK phospho-sites and regulatory module on NBCe1-B and demonstrated SPAK's role in intestinal epithelial barrier and inflammation, broadening its functional reach beyond cation-chloride transport.\",\n      \"evidence\": \"Co-IP/mutagenesis with transporter assays, aldosterone siRNA studies, and knockout mouse barrier and colitis phenotyping\",\n      \"pmids\": [\"23431199\", \"23739593\", \"23499375\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking SPAK to tight junction protein expression unknown\", \"Direct vs indirect effects on barrier function not separated\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrated reciprocal KCC inhibition by SPAK/OSR1 (completing the coordinated Cl- influx/efflux model) and validated CCT-domain Leu502 docking as essential in vivo, while identifying ASK3 as a negative regulator.\",\n      \"evidence\": \"In vitro kinase assays with MO25, double-knockin ES cells, KCC3A Site-2 mutagenesis, L502A knock-in mice, and ASK3 knockout phenotyping\",\n      \"pmids\": [\"24393035\", \"25994507\", \"23250415\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants of NKCC-activating vs KCC-inhibiting substrate selection unclear\", \"ASK3-WNK regulatory mechanism not fully defined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Provided crystal structures of the SPAK kinase domain revealing a regulatory domain-swapped dimer architecture, giving a structural basis for activation and substrate phosphorylation.\",\n      \"evidence\": \"X-ray crystallography of wild-type and T243D SPAK with monomeric-mutant functional assays\",\n      \"pmids\": [\"26208601\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full activated state with substrate not captured\", \"Functional role of dimerization in vivo not established\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showed via DCT-specific constitutively active SPAK mice that hyperactive SPAK alone causes thiazide-treatable hypertension with downstream ASDN remodeling, directly proving SPAK as a driver of salt-sensitive hypertension.\",\n      \"evidence\": \"Conditional CA-SPAK knock-in mice, blood pressure telemetry, thiazide rescue, and phospho-specific IHC/Western\",\n      \"pmids\": [\"28442491\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of ENaC/ROMK downregulation downstream of NCC hyperactivity not fully defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Advanced SPAK as a druggable target by identifying ATP-independent inhibitors binding the CCT or kinase domain, establishing distinct allosteric inhibition strategies.\",\n      \"evidence\": \"In silico screening, biochemical binding, and in vitro/cell-based kinase inhibition assays (rafoxanide, verteporfin)\",\n      \"pmids\": [\"28371477\", \"29999233\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo selectivity and efficacy not established in these reports\", \"Binding-site structural detail limited\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrated therapeutic potential of selective SPAK inhibition in CNS disease by reducing NKCC1 phosphorylation and CSF hypersecretion and improving stroke/edema outcomes, linking SPAK control of brain ion transport to neurological pathology.\",\n      \"evidence\": \"ZT-1a treatment in rodent hydrocephalus and stroke models with CCC phosphorylation and brain water readouts\",\n      \"pmids\": [\"31911626\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-type-specific contributions in brain not dissected\", \"Long-term consequences of SPAK inhibition undefined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Revealed novel SPAK functions in cancer—a PLK1-dependent pro-tumor role and direct SNAI1 Thr203 phosphorylation stabilizing SNAI1 to drive EMT/metastasis—and refined the rapid K+-triggered 'off-switch' regulation of NCC phosphorylation.\",\n      \"evidence\": \"Mass spec, co-IP, in vitro kinase/SNAI1 mutagenesis with xenograft rescue, and in vitro/ex vivo/in vivo K+ phosphatase studies\",\n      \"pmids\": [\"33500714\", \"34335956\", \"33719576\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphatase mediating rapid K+-induced dephosphorylation unidentified\", \"Mechanistic basis of SPAK-PLK1 cooperation in ERK activation unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How SPAK selects between activating NKCCs and inhibiting KCCs at the catalytic level, the identity of the phosphatase(s) executing rapid in vivo dephosphorylation, and the reconciliation of its transport-kinase role with its emerging oncogenic SNAI1/PLK1 functions remain open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model of substrate-specific opposing outputs\", \"In vivo dephosphorylating phosphatase undefined\", \"Transport vs cancer functions not mechanistically connected\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [5, 6, 10, 25, 34, 45]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [4, 5, 31, 45]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 27]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0006873\", \"supporting_discovery_ids\": [5, 34]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [5, 25, 34]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 14, 30]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"WNK1\", \"WNK4\", \"WNK3\", \"NKCC1\", \"NCC\", \"NKCC2\", \"MO25\", \"OSR1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}